Suppressive	O
effects	O
of	O
anti-inflammatory	O
agents	O
on	O
human	B-cell_type
endothelial	I-cell_type
cell	I-cell_type
activation	O
and	O
induction	O
of	O
heat	B-protein
shock	I-protein
proteins	I-protein
.	O

BACKGROUND	O
:	O
Studies	O
from	O
our	O
laboratory	O
have	O
shown	O
that	O
the	O
earliest	O
stages	O
of	O
atherosclerosis	O
may	O
be	O
mediated	O
by	O
an	O
autoimmune	O
reaction	O
against	O
heat	B-protein
shock	I-protein
protein	I-protein
60	I-protein
(	O
Hsp60	B-protein
)	O
.	O

The	O
interactions	O
of	O
Hsp60-specific	B-cell_line
T	I-cell_line
cells	I-cell_line
with	O
arterial	O
endothelial	B-cell_type
cells	I-cell_type
(	O
EC	B-cell_type
)	O
require	O
expression	O
of	O
both	O
Hsp60	B-protein
and	O
certain	O
adhesion	B-protein
molecules	I-protein
shown	O
to	O
be	O
induced	O
simultaneously	O
in	O
EC	B-cell_type
by	O
mechanical	O
and	O
other	O
types	O
of	O
stress	O
.	O

Recently	O
,	O
it	O
was	O
shown	O
that	O
suppression	O
of	O
T	O
cell-mediated	O
immune	O
responses	O
by	O
cyclosporin	O
A	O
(	O
CyA	O
)	O
enhanced	O
atherosclerotic	O
lesion	O
formation	O
in	O
mice	O
.	O

In	O
contrast	O
,	O
aspirin	O
was	O
found	O
to	O
lower	O
the	O
risk	O
of	O
myocardial	O
infarction	O
in	O
men	O
.	O

These	O
conflicting	O
observations	O
may	O
be	O
due	O
to	O
different	O
effects	O
of	O
anti-inflammatory	O
agents	O
on	O
adhesion	O
molecule	O
and	O
Hsp	O
expression	O
in	O
EC	B-cell_type
,	O
respectively	O
.	O

MATERIAL	O
AND	O
METHODS	O
:	O
In	O
the	O
present	O
study	O
,	O
we	O
analyzed	O
the	O
effects	O
of	O
CyA	O
,	O
aspirin	O
,	O
and	O
indomethacin	O
on	O
T	O
cell	O
proliferation	O
using	O
a	O
proliferation	O
assay	O
.	O

To	O
explore	O
the	O
expression	O
of	O
adhesion	B-protein
molecules	I-protein
,	O
monocyte	B-protein
chemoattractant	I-protein
protein-1	I-protein
(	O
MCP-1	B-protein
)	O
,	O
and	O
Hsp60	B-protein
in	O
human	B-cell_type
umbilical	I-cell_type
vein	I-cell_type
endothelial	I-cell_type
cells	I-cell_type
(	O
HUVECs	B-cell_type
)	O
,	O
Northern	O
blot	O
analyses	O
were	O
used	O
.	O

To	O
examine	O
the	O
activation	O
status	O
of	O
the	O
transcription	B-protein
factors	I-protein
nuclear	B-protein
factor	I-protein
kappaB	I-protein
(	O
NF-kappaB	B-protein
)	O
and	O
heat	B-protein
shock	I-protein
factor-1	I-protein
(	O
HSF-1	B-protein
)	O
,	O
electrophoretic	O
mobility	O
shift	O
assays	O
were	O
performed	O
.	O

RESULTS	O
:	O
With	O
the	O
exception	O
of	O
indomethacin	O
,	O
the	O
used	O
immunosuppressive	O
and	O
anti-inflammatory	O
agents	O
significantly	O
inhibited	O
T	O
cell	O
proliferation	O
in	O
response	O
to	O
influenza	B-protein
virus	I-protein
antigen	I-protein
in	O
a	O
dose-dependent	O
manner	O
.	O

Interestingly	O
,	O
CyA	O
and	O
indomethacin	O
did	O
not	O
suppress	O
tumor	B-protein
necrosis	I-protein
factor-alpha	I-protein
(	O
TNF-alpha	B-protein
)	O
-induced	O
adhesion	O
molecule	O
expression	O
on	O
HUVECs	B-cell_type
,	O
whereas	O
aspirin	O
had	O
an	O
inhibitory	O
effect	O
.	O

These	O
observations	O
correlated	O
with	O
the	O
modulation	O
of	O
NF-kappaB	B-protein
activity	O
in	O
EC	B-cell_type
.	O

All	O
agents	O
tested	O
induced	O
expression	O
of	O
Hsp60	B-protein
6	O
hr	O
after	O
application	O
.	O

In	O
addition	O
,	O
aspirin	O
and	O
indomethacin	O
,	O
but	O
not	O
CyA	O
,	O
induced	O
Hsp70	B-protein
expression	O
in	O
HUVECs	B-cell_type
that	O
correlated	O
with	O
induction	O
of	O
HSF-1	B-protein
activity	O
.	O

CONCLUSION	O
:	O
Our	O
results	O
show	O
that	O
the	O
tested	O
agents	O
(	O
except	O
indomethacin	O
)	O
are	O
inhibitors	O
of	O
the	O
T	O
cell-mediated	O
immune	O
response	O
,	O
as	O
expected	O
,	O
that	O
aspirin	O
is	O
an	O
effective	O
suppressor	O
of	O
adhesion	B-protein
molecule	I-protein
expression	O
,	O
and	O
that	O
all	O
three	O
agents	O
can	O
induce	O
Hsp60	B-protein
in	O
HUVECs	B-cell_type
.	O

These	O
data	O
provide	O
the	O
molecular	O
basis	O
for	O
the	O
notion	O
that	O
(	O
1	O
)	O
part	O
of	O
the	O
anti-atherogenic	O
effect	O
of	O
aspirin	O
may	O
be	O
due	O
to	O
the	O
prevention	O
of	O
the	O
adhesion	O
of	O
sensitized	B-cell_type
T	I-cell_type
cells	I-cell_type
to	O
stressed	O
EC	B-cell_type
;	O
(	O
2	O
)	O
that	O
part	O
of	O
the	O
atherosclerosis-promoting	O
effect	O
of	O
CyA	O
may	O
be	O
due	O
to	O
its	O
potential	O
as	O
an	O
inducer	O
of	O
Hsp60	B-protein
expression	O
and	O
its	O
inability	O
to	O
down-regulate	O
adhesion	B-protein
molecule	I-protein
expression	O
on	O
EC	B-cell_type
;	O
and	O
(	O
3	O
)	O
that	O
down-regulation	O
of	O
MCP-1	B-protein
expression	O
by	O
aspirin	O
may	O
result	O
in	O
decreased	O
recruitment	O
of	O
monocytes	B-cell_type
into	O
the	O
arterial	O
intima	O
beneath	O
stressed	O
EC	B-cell_type
.	O

Molecular	NULL
Medicine	NULL
5	NULL
:	NULL
117-128	NULL
,	NULL
1999	NULL
Molecular	NULL
Medicine	NULL
©	NULL
1999	NULL
The	NULL
Picower	NULL
Institute	NULL
Press	NULL
Suppressive	NULL
Effects	NULL
of	NULL
Anti-inflammatory	NULL
Agents	NULL
on	NULL
Human	NULL
Endothelial	NULL
Cell	NULL
Activation	NULL
and	NULL
Induction	NULL
of	NULL
Heat	NULL
Shock	NULL
Proteins	NULL
Albert	NULL
Amberger	NULL
,	NULL
'	NULL
Monika	NULL
Hala	NULL
,	NULL
Maria	NULL
Saurwein-Teissl	NULL
,	NULL
'	NULL
Bernhard	NULL
Metzler	NULL
,	NULL
'	NULL
Beatrix	NULL
Grubeck-Loebenstein	NULL
,	NULL
'	NULL
Qingbo	NULL
Xu	NULL
,	NULL
'	NULL
and	NULL
Georg	NULL
Wick	NULL
``	NULL
'Institute	NULL
for	NULL
Biomedical	NULL
Aging	NULL
Research	NULL
,	NULL
Austrian	NULL
Academy	NULL
of	NULL
Sciences	NULL
,	NULL
Innsbruck	NULL
,	NULL
Austria	NULL
*Institute	NULL
for	NULL
General	NULL
and	NULL
Experimental	NULL
Pathology	NULL
,	NULL
Medical	NULL
School	NULL
,	NULL
University	NULL
of	NULL
Innsbruck	NULL
,	NULL
Innsbruck	NULL
,	NULL
Austria	NULL
Accepted	NULL
December	NULL
23	NULL
,	NULL
1998	NULL
.	NULL

Abstract	NULL
Background	NULL
:	NULL
Studies	NULL
from	NULL
our	NULL
laboratory	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
earliest	NULL
stages	NULL
of	NULL
atherosclerosis	NULL
may	NULL
be	NULL
mediated	NULL
by	NULL
an	NULL
autoimmune	NULL
reaction	NULL
against	NULL
heat	NULL
shock	NULL
protein	NULL
60	NULL
(	NULL
Hsp60	NULL
)	NULL
.	NULL

The	NULL
interactions	NULL
of	NULL
Hsp60-specific	NULL
T	NULL
cells	NULL
with	NULL
arterial	NULL
endothelial	NULL
cells	NULL
(	NULL
EC	NULL
)	NULL
require	NULL
expression	NULL
of	NULL
both	NULL
Hsp60	NULL
and	NULL
certain	NULL
adhesion	NULL
molecules	NULL
shown	NULL
to	NULL
be	NULL
induced	NULL
simultaneously	NULL
in	NULL
EC	NULL
by	NULL
mechanical	NULL
and	NULL
other	NULL
types	NULL
of	NULL
stress	NULL
.	NULL

Recently	NULL
,	NULL
it	NULL
was	NULL
shown	NULL
that	NULL
suppression	NULL
of	NULL
T	NULL
cell-mediated	NULL
immune	NULL
responses	NULL
by	NULL
cyclosporin	NULL
A	NULL
(	NULL
CyA	NULL
)	NULL
enhanced	NULL
atherosclerotic	NULL
lesion	NULL
formation	NULL
in	NULL
mice	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
aspirin	NULL
was	NULL
found	NULL
to	NULL
lower	NULL
the	NULL
risk	NULL
of	NULL
myocardial	NULL
infarction	NULL
in	NULL
men	NULL
.	NULL

These	NULL
conflicting	NULL
observations	NULL
may	NULL
be	NULL
due	NULL
to	NULL
different	NULL
effects	NULL
of	NULL
anti-inflammatory	NULL
agents	NULL
on	NULL
adhesion	NULL
molecule	NULL
and	NULL
Hsp	NULL
expression	NULL
in	NULL
EC	NULL
,	NULL
respectively	NULL
.	NULL

Material	NULL
and	NULL
Methods	NULL
:	NULL
In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
effects	NULL
of	NULL
CyA	NULL
,	NULL
aspirin	NULL
,	NULL
and	NULL
indomethacin	NULL
on	NULL
T	NULL
cell	NULL
proliferation	NULL
using	NULL
a	NULL
proliferation	NULL
assay	NULL
.	NULL

To	NULL
explore	NULL
the	NULL
expression	NULL
of	NULL
adhesion	NULL
molecules	NULL
,	NULL
monocyte	NULL
chemoattractant	NULL
protein-1	NULL
(	NULL
MCP-1	NULL
)	NULL
,	NULL
and	NULL
Hsp60	NULL
in	NULL
human	NULL
umbilical	NULL
vein	NULL
endothelial	NULL
cells	NULL
(	NULL
HUVECs	NULL
)	NULL
,	NULL
Northern	NULL
blot	NULL
analyses	NULL
were	NULL
used	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
activation	NULL
status	NULL
of	NULL
the	NULL
transcription	NULL
factors	NULL
nuclear	NULL
factor	NULL
«	NULL
B	NULL
(	NULL
NF-	NULL
«	NULL
B	NULL
)	NULL
and	NULL
heat	NULL
shock	NULL
factor-1	NULL
(	NULL
HSF-1	NULL
)	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
were	NULL
performed	NULL
.	NULL

Results	NULL
:	NULL
With	NULL
the	NULL
exception	NULL
of	NULL
indomethacin	NULL
,	NULL
the	NULL
used	NULL
immunosuppressive	NULL
and	NULL
anti-inflammatory	NULL
agents	NULL
sig-	NULL
nificantly	NULL
inhibited	NULL
T	NULL
cell	NULL
proliferation	NULL
in	NULL
response	NULL
to	NULL
influenza	NULL
virus	NULL
antigen	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
.	NULL

Interestingly	NULL
,	NULL
CyA	NULL
and	NULL
indomethacin	NULL
did	NULL
not	NULL
suppress	NULL
tumor	NULL
necrosis	NULL
factor-a	NULL
(	NULL
TNF-a	NULL
«	NULL
)	NULL
-induced	NULL
adhesion	NULL
molecule	NULL
expression	NULL
on	NULL
HUVECs	NULL
,	NULL
whereas	NULL
aspirin	NULL
had	NULL
an	NULL
inhibitory	NULL
effect	NULL
.	NULL

These	NULL
observations	NULL
correlated	NULL
with	NULL
the	NULL
modulation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
in	NULL
EC	NULL
.	NULL

All	NULL
agents	NULL
tested	NULL
induced	NULL
expression	NULL
of	NULL
Hsp60	NULL
6	NULL
hr	NULL
after	NULL
application	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
aspirin	NULL
and	NULL
indomethacin	NULL
,	NULL
but	NULL
not	NULL
CyA	NULL
,	NULL
induced	NULL
Hsp70	NULL
expression	NULL
in	NULL
HUVECs	NULL
that	NULL
correlated	NULL
with	NULL
induction	NULL
of	NULL
HSF-1	NULL
activity	NULL
.	NULL

Conclusion	NULL
:	NULL
Our	NULL
results	NULL
show	NULL
that	NULL
the	NULL
tested	NULL
agents	NULL
(	NULL
except	NULL
indomethacin	NULL
)	NULL
are	NULL
inhibitors	NULL
of	NULL
the	NULL
T	NULL
cell-mediated	NULL
immune	NULL
response	NULL
,	NULL
as	NULL
expected	NULL
,	NULL
that	NULL
aspirin	NULL
is	NULL
an	NULL
effective	NULL
suppressor	NULL
of	NULL
adhesion	NULL
molecule	NULL
expression	NULL
,	NULL
and	NULL
that	NULL
all	NULL
three	NULL
agents	NULL
can	NULL
induce	NULL
Hsp60	NULL
in	NULL
HUVECs	NULL
.	NULL

These	NULL
data	NULL
provide	NULL
the	NULL
molecular	NULL
basis	NULL
for	NULL
the	NULL
notion	NULL
that	NULL
(	NULL
1	NULL
)	NULL
part	NULL
of	NULL
the	NULL
anti-atherogenic	NULL
effect	NULL
of	NULL
aspirin	NULL
may	NULL
be	NULL
due	NULL
to	NULL
the	NULL
prevention	NULL
of	NULL
the	NULL
adhesion	NULL
of	NULL
sensitized	NULL
T	NULL
cells	NULL
to	NULL
stressed	NULL
EC	NULL
;	NULL
(	NULL
2	NULL
)	NULL
that	NULL
part	NULL
of	NULL
the	NULL
atherosclerosis-promoting	NULL
effect	NULL
of	NULL
CyA	NULL
may	NULL
be	NULL
due	NULL
to	NULL
its	NULL
potential	NULL
as	NULL
an	NULL
inducer	NULL
of	NULL
Hsp60	NULL
expression	NULL
and	NULL
its	NULL
inability	NULL
to	NULL
down-regulate	NULL
adhesion	NULL
molecule	NULL
expression	NULL
on	NULL
EC	NULL
;	NULL
and	NULL
(	NULL
3	NULL
)	NULL
that	NULL
down-regulation	NULL
of	NULL
MCP-1	NULL
expression	NULL
by	NULL
aspirin	NULL
may	NULL
result	NULL
in	NULL
decreased	NULL
recruitment	NULL
of	NULL
monocytes	NULL
into	NULL
the	NULL
arterial	NULL
intima	NULL
beneath	NULL
stressed	NULL
EC	NULL
.	NULL

Introduction	NULL
Results	NULL
in	NULL
the	NULL
past	NULL
few	NULL
years	NULL
from	NULL
different	NULL
laboratories	NULL
suggest	NULL
an	NULL
immunological	NULL
contri-	NULL
Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
:	NULL
Georg	NULL
Wick	NULL
,	NULL
M.D	NULL
.	NULL

,	NULL
Institute	NULL
for	NULL
Biomedical	NULL
Aging	NULL
Research	NULL
,	NULL
Austrian	NULL
Academy	NULL
of	NULL
Sciences	NULL
,	NULL
Rennweg	NULL
10	NULL
,	NULL
A-6020	NULL
Innsbruck	NULL
,	NULL
Austria	NULL
.	NULL

Phone	NULL
:	NULL
43-512-58	NULL
39	NULL
19	NULL
,	NULL
or	NULL
43-512-507	NULL
3100	NULL
;	NULL
Fax	NULL
:	NULL
43-512-58	NULL
39	NULL
198	NULL
,	NULL
or	NULL
43-512-507	NULL
2867	NULL
;	NULL
E-mail	NULL
:	NULL
iba	NULL
@	NULL
oeaw.ac.at	NULL
bution	NULL
to	NULL
the	NULL
development	NULL
of	NULL
atherosclerosis	NULL
.	NULL

It	NULL
was	NULL
shown	NULL
that	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
macrophages	NULL
,	NULL
T	NULL
lymphocytes	NULL
are	NULL
also	NULL
a	NULL
fundamental	NULL
component	NULL
of	NULL
early	NULL
atherosclerotic	NULL
lesions	NULL
(	NULL
1,2	NULL
)	NULL
,	NULL
and	NULL
these	NULL
T	NULL
lymphocytes	NULL
are	NULL
predominantly	NULL
CD4	NULL
*	NULL
interleukin-2	NULL
(	NULL
IL-2R	NULL
)	NULL
and	NULL
HLA-DR	NULL
receptor	NULL
positive	NULL
,	NULL
indicating	NULL
an	NULL
activated	NULL
phenotype	NULL
(	NULL
3,4	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
it	NULL
was	NULL
shown	NULL
that	NULL
atheroscle-	NULL
118	NULL
Molecular	NULL
Medicine	NULL
,	NULL
Volume	NULL
5	NULL
,	NULL
Number	NULL
2	NULL
,	NULL
February	NULL
1999	NULL
rotic	NULL
lesions	NULL
induced	NULL
in	NULL
mice	NULL
or	NULL
rabbits	NULL
(	NULL
5,6	NULL
)	NULL
by	NULL
a	NULL
high	NULL
cholesterol	NULL
diet	NULL
also	NULL
exhibit	NULL
infiltration	NULL
and	NULL
activation	NULL
of	NULL
T	NULL
lymphocytes	NULL
.	NULL

Based	NULL
on	NULL
observations	NULL
in	NULL
humans	NULL
and	NULL
experimental	NULL
animals	NULL
,	NULL
we	NULL
have	NULL
advanced	NULL
an	NULL
immunological	NULL
hypothesis	NULL
for	NULL
atherogenesis	NULL
(	NULL
7,8	NULL
)	NULL
,	NULL
in	NULL
which	NULL
cellular	NULL
and	NULL
humoral	NULL
immune	NULL
reactions	NULL
to	NULL
heat	NULL
shock	NULL
protein	NULL
60	NULL
(	NULL
Hsp60	NULL
)	NULL
have	NULL
been	NULL
identified	NULL
as	NULL
the	NULL
initiating	NULL
factors	NULL
.	NULL

This	NULL
hypothesis	NULL
is	NULL
corroborated	NULL
by	NULL
the	NULL
finding	NULL
that	NULL
immunization	NULL
of	NULL
normocholesterolemic	NULL
rabbits	NULL
with	NULL
recombi-nant	NULL
mycobacterial	NULL
heat	NULL
shock	NULL
protein	NULL
65	NULL
(	NULL
Hsp65	NULL
)	NULL
induces	NULL
the	NULL
development	NULL
of	NULL
arterioscle-rotic	NULL
lesions	NULL
,	NULL
and	NULL
that	NULL
the	NULL
majority	NULL
of	NULL
T	NULL
lymphocytes	NULL
isolated	NULL
from	NULL
these	NULL
lesions	NULL
react	NULL
against	NULL
Hsp65	NULL
in	NULL
vitro	NULL
(	NULL
5,9	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
an	NULL
epidemio-logical	NULL
study	NULL
showed	NULL
that	NULL
serum	NULL
antibody	NULL
titers	NULL
to	NULL
hsp65	NULL
were	NULL
significantly	NULL
increased	NULL
in	NULL
clinically	NULL
healthy	NULL
subjects	NULL
with	NULL
sonographically	NULL
demonstrable	NULL
carotid	NULL
atherosclerosis	NULL
compared	NULL
to	NULL
those	NULL
without	NULL
lesions	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Hsp65	NULL
belongs	NULL
to	NULL
a	NULL
family	NULL
of	NULL
proteins	NULL
induced	NULL
by	NULL
various	NULL
forms	NULL
of	NULL
stress	NULL
,	NULL
such	NULL
as	NULL
temperature	NULL
,	NULL
cytokines	NULL
,	NULL
toxins	NULL
,	NULL
and	NULL
oxidized	NULL
low-density	NULL
lipoproteins	NULL
.	NULL

One	NULL
of	NULL
their	NULL
important	NULL
functions	NULL
is	NULL
protecting	NULL
other	NULL
cellular	NULL
proteins	NULL
from	NULL
denaturation	NULL
to	NULL
maintain	NULL
their	NULL
cellular	NULL
functions	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Hsps	NULL
are	NULL
phylogenetically	NULL
highly	NULL
conserved	NULL
;	NULL
mycobacterial	NULL
Hsp65	NULL
exhibits	NULL
a	NULL
>	NULL
50	NULL
%	NULL
protein	NULL
sequence	NULL
homology	NULL
to	NULL
human	NULL
Hsp60	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Hsp	NULL
antigens	NULL
are	NULL
also	NULL
important	NULL
in	NULL
inducing	NULL
protective	NULL
immune	NULL
responses	NULL
but	NULL
,	NULL
in	NULL
view	NULL
of	NULL
the	NULL
high	NULL
sequence	NULL
homology	NULL
to	NULL
Hsp60	NULL
,	NULL
this	NULL
protection	NULL
may	NULL
have	NULL
to	NULL
be	NULL
``	NULL
paid	NULL
for	NULL
``	NULL
in	NULL
humans	NULL
by	NULL
an	NULL
autoimmune	NULL
cross-reaction	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Previous	NULL
studies	NULL
suggested	NULL
that	NULL
recruitment	NULL
of	NULL
activated	NULL
T	NULL
lymphocytes	NULL
into	NULL
inflammation	NULL
sites	NULL
is	NULL
mediated	NULL
by	NULL
several	NULL
adhesion	NULL
molecules	NULL
,	NULL
e.g	NULL
.	NULL

,	NULL
the	NULL
intercellular	NULL
adhesion	NULL
molecule-1	NULL
(	NULL
ICAM-1	NULL
)	NULL
,	NULL
vascular	NULL
cell	NULL
adhesion	NULL
molecule-1	NULL
(	NULL
VCAM-1	NULL
)	NULL
,	NULL
endothelial	NULL
leukocyte	NULL
adhesion	NULL
molecule-1	NULL
(	NULL
ELAM-1	NULL
;	NULL
E-selectin	NULL
)	NULL
,	NULL
and	NULL
chemoattractant	NULL
proteins	NULL
,	NULL
such	NULL
as	NULL
monocyte	NULL
chemoattractant	NULL
protein-1	NULL
(	NULL
MCP-1	NULL
)	NULL
,	NULL
expressed	NULL
by	NULL
endothelial	NULL
cells	NULL
.	NULL

This	NULL
mechanism	NULL
was	NULL
also	NULL
suggested	NULL
for	NULL
the	NULL
recruitment	NULL
of	NULL
T	NULL
lymphocytes	NULL
into	NULL
the	NULL
arterial	NULL
wall	NULL
(	NULL
14,15	NULL
)	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
adhesion	NULL
molecule	NULL
expression	NULL
in	NULL
endothelial	NULL
cells	NULL
overlaying	NULL
atherosclerotic	NULL
lesions	NULL
has	NULL
been	NULL
demonstrated	NULL
(	NULL
16-18	NULL
)	NULL
,	NULL
and	NULL
data	NULL
from	NULL
our	NULL
laboratory	NULL
revealed	NULL
that	NULL
different	NULL
stressors	NULL
,	NULL
such	NULL
as	NULL
hemodynamic	NULL
turbulance	NULL
,	NULL
H	NULL
;	NULL
,0	NULL
;	NULL
,	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
(	NULL
TNF-a	NULL
)	NULL
,	NULL
and	NULL
E.	NULL
coli	NULL
lipopolysaccharide	NULL
,	NULL
induce	NULL
co-expression	NULL
of	NULL
adhesion	NULL
molecules	NULL
and	NULL
Hsp60	NULL
in	NULL
endothelial	NULL
cells	NULL
in	NULL
vivo	NULL
and	NULL
in	NULL
vitro	NULL
(	NULL
19,20	NULL
)	NULL
,	NULL
providing	NULL
the	NULL
prerequisites	NULL
for	NULL
recruitment	NULL
of	NULL
anti-Hsp6O-reactive	NULL
T	NULL
cells	NULL
into	NULL
the	NULL
arterial	NULL
intima	NULL
and	NULL
subsequent	NULL
initiation	NULL
of	NULL
an	NULL
autoimmune	NULL
response	NULL
.	NULL

The	NULL
role	NULL
of	NULL
immune	NULL
reactions	NULL
in	NULL
atherogenesis	NULL
was	NULL
analyzed	NULL
by	NULL
manipulating	NULL
the	NULL
immune	NULL
system	NULL
in	NULL
various	NULL
animal	NULL
models	NULL
of	NULL
atherosclerosis	NULL
.	NULL

Cyclosporin	NULL
A	NULL
(	NULL
CyA	NULL
)	NULL
-mediated	NULL
T	NULL
lymphocyte	NULL
immunosuppression	NULL
of	NULL
rabbits	NULL
and	NULL
mice	NULL
fed	NULL
a	NULL
cholesterol-rich	NULL
diet	NULL
resulted	NULL
in	NULL
enhanced	NULL
atherosclerosis	NULL
(	NULL
21,22	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
aspirin	NULL
,	NULL
another	NULL
anti-inflammatory	NULL
agent	NULL
,	NULL
lowered	NULL
the	NULL
incidence	NULL
of	NULL
myocardial	NULL
infarction	NULL
and	NULL
stroke	NULL
in	NULL
men	NULL
(	NULL
23	NULL
)	NULL
.	NULL

These	NULL
conflicting	NULL
observations	NULL
may	NULL
result	NULL
from	NULL
different	NULL
mechanisms	NULL
of	NULL
action	NULL
of	NULL
these	NULL
immunosuppressive	NULL
and	NULL
anti-inflammatory	NULL
agents	NULL
on	NULL
adhesion	NULL
molecule	NULL
and	NULL
Hsp	NULL
expression	NULL
,	NULL
respec-tively	NULL
,	NULL
in	NULL
endothelial	NULL
cells	NULL
.	NULL

Transcriptional	NULL
induction	NULL
of	NULL
the	NULL
corresponding	NULL
genes	NULL
by	NULL
various	NULL
stres-sors	NULL
is	NULL
mediated	NULL
by	NULL
transcription	NULL
factors	NULL
that	NULL
bind	NULL
to	NULL
specific	NULL
DNA	NULL
elements	NULL
in	NULL
the	NULL
promotor	NULL
region	NULL
of	NULL
these	NULL
genes	NULL
.	NULL

Transcription	NULL
factors	NULL
,	NULL
such	NULL
as	NULL
nuclear	NULL
factor-	NULL
«	NULL
B	NULL
(	NULL
NF-KB	NULL
)	NULL
and	NULL
heat	NULL
shock	NULL
factor-1	NULL
(	NULL
HSF-1	NULL
)	NULL
,	NULL
are	NULL
pleiotropic	NULL
regulators	NULL
of	NULL
many	NULL
genes	NULL
involved	NULL
in	NULL
immune	NULL
and	NULL
inflammatory	NULL
re-sponses	NULL
,	NULL
including	NULL
adhesion	NULL
molecules	NULL
and	NULL
Hsps	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Most	NULL
studies	NULL
analyzing	NULL
the	NULL
effects	NULL
of	NULL
anti-inflammatory	NULL
agents	NULL
focused	NULL
on	NULL
the	NULL
modulation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
by	NULL
aspirin	NULL
in	NULL
cytokine-stimu-lated	NULL
endothelial	NULL
cells	NULL
(	NULL
25,26	NULL
)	NULL
.	NULL

However	NULL
,	NULL
little	NULL
is	NULL
known	NULL
about	NULL
the	NULL
action	NULL
of	NULL
immunosuppressive	NULL
agents	NULL
on	NULL
the	NULL
activity	NULL
of	NULL
other	NULL
transcription	NULL
factors	NULL
in	NULL
endothelial	NULL
cells	NULL
and	NULL
their	NULL
potential	NULL
to	NULL
induce	NULL
adhesion	NULL
molecule	NULL
and	NULL
Hsp	NULL
expression	NULL
.	NULL

To	NULL
detail	NULL
the	NULL
potential	NULL
role	NULL
of	NULL
immunosuppressive	NULL
and	NULL
anti-inflammatory	NULL
agents	NULL
in	NULL
atherosclerosis	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
effects	NULL
of	NULL
CyA	NULL
,	NULL
aspirin	NULL
,	NULL
and	NULL
indomethacin	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
ICAM-	NULL
1	NULL
,	NULL
VCAM-1	NULL
,	NULL
ELAM-1	NULL
,	NULL
and	NULL
MCP-1	NULL
,	NULL
and	NULL
of	NULL
Hsp60	NULL
and	NULL
Hsp70	NULL
by	NULL
endothelial	NULL
cells	NULL
after	NULL
cytokine	NULL
activation	NULL
in	NULL
vitro	NULL
.	NULL

In	NULL
parallel	NULL
,	NULL
the	NULL
efficiency	NULL
of	NULL
this	NULL
treatment	NULL
was	NULL
assessed	NULL
by	NULL
analyzing	NULL
peripheral	NULL
blood	NULL
lymphocyte	NULL
proliferation	NULL
in	NULL
response	NULL
to	NULL
specific	NULL
antigen	NULL
stimulation	NULL
(	NULL
influenza	NULL
viri-ons	NULL
)	NULL
.	NULL

We	NULL
also	NULL
analyzed	NULL
the	NULL
role	NULL
of	NULL
transcription	NULL
factor	NULL
activity	NULL
in	NULL
endothelial	NULL
cells	NULL
after	NULL
treatment	NULL
with	NULL
these	NULL
agents	NULL
to	NULL
demonstrate	NULL
how	NULL
the	NULL
effects	NULL
of	NULL
the	NULL
immunosuppressive	NULL
agents	NULL
are	NULL
mediated	NULL
in	NULL
endothelial	NULL
cells	NULL
on	NULL
a	NULL
molecular	NULL
level	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Isolation	NULL
and	NULL
In	NULL
Vitro	NULL
Culture	NULL
of	NULL
Peripheral	NULL
Blood	NULL
Mononuclear	NULL
Cells	NULL
(	NULL
PBMC	NULL
)	NULL
PBMC	NULL
from	NULL
fifteen	NULL
20	NULL
to	NULL
35-year-old	NULL
donors	NULL
,	NULL
11	NULL
female	NULL
and	NULL
4	NULL
male	NULL
,	NULL
were	NULL
purified	NULL
from	NULL
heparin-ized	NULL
blood	NULL
by	NULL
Ficoll-Paque	NULL
(	NULL
Pharmacia	NULL
,	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
)	NULL
density	NULL
centrifugation	NULL
and	NULL
washed	NULL
twice	NULL
in	NULL
RPMI	NULL
1640	NULL
from	NULL
Gibco	NULL
(	NULL
Grand	NULL
Island	NULL
,	NULL
NY	NULL
)	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

The	NULL
cells	NULL
(	NULL
10°/well	NULL
)	NULL
A.	NULL
Amberger	NULL
et	NULL
al	NULL
.	NULL

:	NULL
Effects	NULL
of	NULL
Anti-inflammatory	NULL
Agents	NULL
on	NULL
HUVECs	NULL
119	NULL
were	NULL
placed	NULL
into	NULL
96-well	NULL
flat-bottom	NULL
microtiter	NULL
plates	NULL
(	NULL
Falcon	NULL
,	NULL
Becton	NULL
Dickinson	NULL
,	NULL
Lincoln	NULL
Park	NULL
,	NULL
NJ	NULL
)	NULL
containing	NULL
RPMI-1640	NULL
medium	NULL
,	NULL
supplemented	NULL
with	NULL
antibiotics	NULL
(	NULL
penicillin	NULL
10,000	NULL
U/ml	NULL
,	NULL
streptomycin	NULL
10	NULL
mg/ml	NULL
,	NULL
Gibco	NULL
)	NULL
and	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
SEBAK	NULL
,	NULL
Stuben	NULL
,	NULL
Austria	NULL
)	NULL
as	NULL
culture	NULL
medium	NULL
.	NULL

Inactivated	NULL
intact	NULL
influenza	NULL
virions	NULL
of	NULL
three	NULL
strains	NULL
[	NULL
Singapore/6/86	NULL
(	NULL
HIN1	NULL
)	NULL
,	NULL
A/Johan-nesburg/33/94	NULL
(	NULL
H3N2	NULL
)	NULL
,	NULL
or	NULL
B/Beijing/184/93	NULL
;	NULL
1	NULL
mg/m	NULL
!	NULL

;	NULL
Inflexal-Berna®	NULL
,	NULL
kindly	NULL
provided	NULL
by	NULL
the	NULL
Schweizer	NULL
Serum	NULL
&	NULL
Impfinstitut	NULL
Bern	NULL
,	NULL
Switzer-land	NULL
]	NULL
were	NULL
added	NULL
for	NULL
stimulation	NULL
.	NULL

Nonspecific	NULL
stimulation	NULL
of	NULL
PBMC	NULL
by	NULL
phytohemagglutinin	NULL
(	NULL
PHA	NULL
)	NULL
(	NULL
1	NULL
ug/ml	NULL
,	NULL
Sigma	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
was	NULL
performed	NULL
as	NULL
control	NULL
.	NULL

PBMC	NULL
were	NULL
then	NULL
cultured	NULL
in	NULL
a	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
atmosphere	NULL
at	NULL
37°C	NULL
for	NULL
7	NULL
days	NULL
and	NULL
finally	NULL
pulsed	NULL
with	NULL
1	NULL
mCi	NULL
of	NULL
*H-thymidine	NULL
(	NULL
Am-ersham	NULL
,	NULL
Buckinghamshire	NULL
,	NULL
UK	NULL
)	NULL
for	NULL
8	NULL
hr	NULL
.	NULL

All	NULL
assays	NULL
were	NULL
carried	NULL
out	NULL
in	NULL
triplicate	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
and	NULL
proliferation	NULL
rates	NULL
determined	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
27	NULL
)	NULL
.	NULL

PBMC	NULL
from	NULL
each	NULL
donor	NULL
were	NULL
cultured	NULL
at	NULL
37°C	NULL
,	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
,	NULL
and	NULL
analyzed	NULL
for	NULL
in	NULL
vitro	NULL
proliferation	NULL
in	NULL
response	NULL
to	NULL
stimulation	NULL
with	NULL
inactivated	NULL
influenza	NULL
virus	NULL
.	NULL

Endothelial	NULL
Cell	NULL
(	NULL
EC	NULL
)	NULL
Preparation	NULL
and	NULL
Culture	NULL
Human	NULL
umbilical	NULL
vein	NULL
endothelial	NULL
cells	NULL
(	NULL
HU-VECs	NULL
)	NULL
were	NULL
isolated	NULL
from	NULL
umbilical	NULL
cords	NULL
(	NULL
ob-tained	NULL
from	NULL
the	NULL
Department	NULL
of	NULL
Gynecology	NULL
and	NULL
Obstrestics	NULL
,	NULL
University	NULL
of	NULL
Innsbruck	NULL
)	NULL
by	NULL
collage-nase	NULL
IV	NULL
(	NULL
1	NULL
mg/ml	NULL
!	NULL

in	NULL
RPMI	NULL
1640	NULL
medium	NULL
;	NULL
Sigma	NULL
,	NULL
Munich	NULL
)	NULL
digestion	NULL
for	NULL
20	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

HUVECs	NULL
were	NULL
harvested	NULL
and	NULL
cultivated	NULL
in	NULL
endothelial	NULL
cell	NULL
medium	NULL
from	NULL
PromoCell	NULL
(	NULL
Hei-delberg	NULL
,	NULL
Germany	NULL
)	NULL
on	NULL
gelatin	NULL
precoated	NULL
(	NULL
0.2	NULL
%	NULL
solution	NULL
,	NULL
type	NULL
B	NULL
,	NULL
Sigma	NULL
)	NULL
culture	NULL
flasks	NULL
(	NULL
Falcon	NULL
,	NULL
Becton	NULL
Dickinson	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
identified	NULL
as	NULL
endothelial	NULL
cells	NULL
(	NULL
EC	NULL
)	NULL
by	NULL
immunofluorescence	NULL
staining	NULL
for	NULL
factor	NULL
VIII	NULL
antigen	NULL
production	NULL
(	NULL
anti-body	NULL
MO616	NULL
from	NULL
Dakopatts	NULL
,	NULL
Glostrup	NULL
,	NULL
Den-mark	NULL
)	NULL
.	NULL

The	NULL
second	NULL
to	NULL
fifth	NULL
passages	NULL
of	NULL
EC	NULL
were	NULL
used	NULL
for	NULL
all	NULL
experiments	NULL
.	NULL

Application	NULL
of	NULL
Immunosuppressive	NULL
Agents	NULL
to	NULL
EC	NULL
EC	NULL
were	NULL
cultivated	NULL
in	NULL
culture	NULL
flasks	NULL
until	NULL
they	NULL
reached	NULL
confluence	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
washed	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
,	NULL
pH	NULL
7.2	NULL
)	NULL
and	NULL
cultivated	NULL
in	NULL
new	NULL
EC	NULL
medium	NULL
supplemented	NULL
with	NULL
TNF-a	NULL
(	NULL
10	NULL
ng/ml	NULL
;	NULL
Sigma	NULL
)	NULL
and	NULL
various	NULL
concentrations	NULL
of	NULL
immunosuppressive	NULL
agents	NULL
,	NULL
or	NULL
with	NULL
immunosuppressive	NULL
agents	NULL
alone	NULL
for	NULL
6	NULL
hr	NULL
.	NULL

Thereafter	NULL
,	NULL
the	NULL
medium	NULL
was	NULL
removed	NULL
and	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
collected	NULL
for	NULL
Northern	NULL
blots	NULL
and	NULL
gel	NULL
shift	NULL
assays	NULL
.	NULL

CyA	NULL
from	NULL
Sandimmune®	NULL
(	NULL
Sandoz	NULL
,	NULL
Switzer-land	NULL
)	NULL
was	NULL
dissolved	NULL
in	NULL
the	NULL
solution	NULL
supplied	NULL
by	NULL
the	NULL
manufacturer	NULL
and	NULL
diluted	NULL
to	NULL
end	NULL
concentrations	NULL
in	NULL
endothelial	NULL
cell	NULL
or	NULL
RPMI	NULL
medium	NULL
.	NULL

Aspirin	NULL
(	NULL
acetylsalicylic	NULL
acid	NULL
,	NULL
Sigma	NULL
)	NULL
was	NULL
dissolved	NULL
in	NULL
EC	NULL
medium	NULL
to	NULL
give	NULL
a	NULL
1	NULL
M	NULL
(	NULL
180.2	NULL
mg/ml	NULL
)	NULL
solution	NULL
.	NULL

The	NULL
pH	NULL
of	NULL
the	NULL
medium	NULL
containing	NULL
aspirin	NULL
was	NULL
adjusted	NULL
prior	NULL
to	NULL
usage	NULL
.	NULL

Indomethacin	NULL
(	NULL
Sig-ma	NULL
)	NULL
was	NULL
dissolved	NULL
in	NULL
dimethylsulfoxide	NULL
(	NULL
DMSO	NULL
;	NULL
Merck	NULL
,	NULL
Darmstadt	NULL
,	NULL
Germany	NULL
)	NULL
to	NULL
prepare	NULL
a	NULL
10	NULL
mg/ml	NULL
solution	NULL
.	NULL

This	NULL
solution	NULL
was	NULL
then	NULL
diluted	NULL
in	NULL
EC	NULL
or	NULL
RPMI	NULL
medium	NULL
to	NULL
the	NULL
final	NULL
concentrations	NULL
given	NULL
in	NULL
the	NULL
Results	NULL
section	NULL
.	NULL

RNA	NULL
Isolation	NULL
and	NULL
Northern	NULL
Blots	NULL
Total	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
EC	NULL
according	NULL
to	NULL
a	NULL
standard	NULL
protocol	NULL
(	NULL
28	NULL
)	NULL
.	NULL

The	NULL
RNA	NULL
was	NULL
electrophoresed	NULL
in	NULL
a	NULL
1	NULL
%	NULL
formaldehyde	NULL
agarose	NULL
gel	NULL
,	NULL
blotted	NULL
on	NULL
a	NULL
nylon	NULL
membrane	NULL
(	NULL
Zeta	NULL
probe	NULL
,	NULL
BioRad	NULL
,	NULL
Rich-mond	NULL
,	NULL
VA	NULL
)	NULL
and	NULL
UV	NULL
cross-linked	NULL
.	NULL

The	NULL
filters	NULL
were	NULL
hybridized	NULL
with	NULL
>	NULL
P-labeled	NULL
cDNA	NULL
(	NULL
°°P-a	NULL
«	NULL
dCTP	NULL
,	NULL
Amersham	NULL
,	NULL
London	NULL
)	NULL
and	NULL
random	NULL
primed	NULL
using	NULL
a	NULL
labeling	NULL
kit	NULL
(	NULL
Boehringer-Mannheim	NULL
,	NULL
Mannheim	NULL
,	NULL
Germany	NULL
)	NULL
for	NULL
ICAM-1	NULL
,	NULL
VCAM-1	NULL
,	NULL
ELAM-1	NULL
,	NULL
Hsp60	NULL
,	NULL
Hsp70	NULL
,	NULL
B-actin	NULL
,	NULL
or	NULL
GAPDH	NULL
at	NULL
63°C	NULL
in	NULL
hybridization	NULL
buffer	NULL
(	NULL
29	NULL
)	NULL
.	NULL

After	NULL
three	NULL
washing	NULL
steps	NULL
,	NULL
filters	NULL
were	NULL
exposed	NULL
to	NULL
X-OMAT	NULL
X-ray	NULL
film	NULL
from	NULL
Kodak	NULL
(	NULL
Rochester	NULL
,	NULL
NY	NULL
)	NULL
at	NULL
-70°C	NULL
.	NULL

The	NULL
cDNA	NULL
clones	NULL
used	NULL
in	NULL
these	NULL
experiments	NULL
were	NULL
the	NULL
same	NULL
as	NULL
described	NULL
earlier	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Extraction	NULL
of	NULL
Nuclear	NULL
Protein	NULL
for	NULL
NF-KB	NULL
and	NULL
HSF-1	NULL
Detection	NULL
EC	NULL
were	NULL
washed	NULL
in	NULL
ice-cold	NULL
PBS	NULL
,	NULL
harvested	NULL
in	NULL
1	NULL
ml	NULL
TE-buffer	NULL
(	NULL
10	NULL
mM	NULL
Tris	NULL
Cl	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
pH	NULL
8	NULL
,	NULL
Merck	NULL
)	NULL
and	NULL
pelleted	NULL
at	NULL
17,000	NULL
x	NULL
g	NULL
for	NULL
5	NULL
min	NULL
.	NULL

The	NULL
pellet	NULL
was	NULL
resuspended	NULL
in	NULL
buffer	NULL
A	NULL
containing	NULL
10	NULL
mM	NULL
Hepes	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
10	NULL
mM	NULL
KC	NULL
]	NULL
,	NULL
0.1	NULL
mM	NULL
EGTA	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
supplemented	NULL
with	NULL
400	NULL
uM	NULL
phenylImethylsulfonyl	NULL
fluoride	NULL
(	NULL
PMSF	NULL
)	NULL
,	NULL
2	NULL
uM	NULL
leupeptin	NULL
,	NULL
10	NULL
U/ml	NULL
aprotinin	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
pefablock	NULL
SC	NULL
[	NULL
4-	NULL
(	NULL
2-aminoethyl	NULL
)	NULL
-benzenesulfo-nyl	NULL
floride	NULL
hydrochloride	NULL
,	NULL
Boehringer-Mann-heim	NULL
]	NULL
and	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
15	NULL
min	NULL
.	NULL

After	NULL
addition	NULL
of	NULL
0.6	NULL
%	NULL
nonidet	NULL
P-40	NULL
(	NULL
Igepal	NULL
CA-630	NULL
,	NULL
Sigma	NULL
)	NULL
,	NULL
the	NULL
nuclei	NULL
were	NULL
pelleted	NULL
at	NULL
17,000	NULL
%	NULL
g	NULL
for	NULL
0.5	NULL
min	NULL
and	NULL
resuspended	NULL
in	NULL
buffer	NULL
B	NULL
containing	NULL
20	NULL
mM	NULL
Hepes	NULL
,	NULL
0.4	NULL
M	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
1.5	NULL
mM	NULL
MgCl	NULL
,	NULL
20	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
mM	NULL
EGTA	NULL
and	NULL
1	NULL
mM	NULL
DTT	NULL
supplemented	NULL
with	NULL
the	NULL
same	NULL
amount	NULL
of	NULL
protease	NULL
inhibitors	NULL
as	NULL
buffer	NULL
A	NULL
.	NULL

After	NULL
incubation	NULL
on	NULL
ice	NULL
for	NULL
15	NULL
min	NULL
and	NULL
continuous	NULL
vortexing	NULL
,	NULL
the	NULL
probes	NULL
were	NULL
centrifuged	NULL
at	NULL
17,000	NULL
%	NULL
g	NULL
for	NULL
5	NULL
min	NULL
.	NULL

120	NULL
Molecular	NULL
Medicine	NULL
,	NULL
Volume	NULL
5	NULL
,	NULL
Number	NULL
2	NULL
,	NULL
February	NULL
1999	NULL
The	NULL
supernatant	NULL
was	NULL
harvested	NULL
and	NULL
protein	NULL
concentration	NULL
measured	NULL
with	NULL
Bio-Rad	NULL
protein	NULL
assay	NULL
reagent	NULL
obtained	NULL
from	NULL
Bio-Rad	NULL
Laboratories	NULL
(	NULL
Richmond	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Electrophoretic	NULL
Mobility	NULL
Shift	NULL
Assays	NULL
(	NULL
EMSA	NULL
)	NULL
NF-KB	NULL
.	NULL

-	NULL
For	NULL
gel	NULL
mobility	NULL
shift	NULL
assays	NULL
,	NULL
5	NULL
ug	NULL
of	NULL
the	NULL
nuclear	NULL
protein	NULL
extract	NULL
was	NULL
incubated	NULL
with	NULL
1	NULL
ng	NULL
of	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
sequence	NULL
labeled	NULL
with	NULL
(	NULL
y-	NULL
>	NULL
``	NULL
P	NULL
)	NULL
ATP	NULL
(	NULL
Amer-sham	NULL
)	NULL
and	NULL
T4-polynucleotide	NULL
kinase	NULL
(	NULL
Strat-agene	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Reaction	NULL
buffer	NULL
contained	NULL
10	NULL
mM	NULL
Tris	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
5	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
and	NULL
1	NULL
pg	NULL
poly	NULL
(	NULL
dIdC	NULL
)	NULL
(	NULL
Pharmacia	NULL
)	NULL
as	NULL
a	NULL
nonspecific	NULL
inhibitor	NULL
.	NULL

Samples	NULL
were	NULL
electrophoresed	NULL
through	NULL
a	NULL
4	NULL
%	NULL
polyacryl-amide	NULL
gel	NULL
and	NULL
exposed	NULL
to	NULL
autoradiographic	NULL
film	NULL
(	NULL
X-OMAT	NULL
,	NULL
Kodak	NULL
)	NULL
.	NULL

HSF-1	NULL
.	NULL

For	NULL
gel	NULL
mobility	NULL
shift	NULL
assays	NULL
,	NULL
5	NULL
ug	NULL
of	NULL
the	NULL
nuclear	NULL
protein	NULL
extract	NULL
was	NULL
incubated	NULL
with	NULL
1	NULL
ng	NULL
of	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
HSF	NULL
binding	NULL
sequence	NULL
(	NULL
HSE	NULL
)	NULL
labeled	NULL
with	NULL
(	NULL
a	NULL
«	NULL
-	NULL
``	NULL
``	NULL
P	NULL
)	NULL
dCTP	NULL
(	NULL
Am-ersham	NULL
)	NULL
and	NULL
the	NULL
Random	NULL
Primed	NULL
DNA	NULL
Labeling	NULL
Kit	NULL
(	NULL
Boehringer-Mannheim	NULL
)	NULL
.	NULL

Reaction	NULL
buffer	NULL
contained	NULL
10	NULL
mM	NULL
Hepes	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
4	NULL
%	NULL
Ficoll	NULL
,	NULL
80	NULL
mM	NULL
KCl	NULL
,	NULL
and	NULL
1	NULL
ug	NULL
poly	NULL
(	NULL
dIdC	NULL
)	NULL
as	NULL
a	NULL
nonspecific	NULL
inhibitor	NULL
.	NULL

Electro-phoresis	NULL
and	NULL
detection	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
for	NULL
NF-KB	NULL
.	NULL

Results	NULL
Suppression	NULL
of	NULL
PBMC	NULL
Proliferation	NULL
by	NULL
Immunosuppressive	NULL
Agents	NULL
In	NULL
Vitro	NULL
To	NULL
functionally	NULL
assess	NULL
immunosuppression	NULL
by	NULL
anti-inflammatory	NULL
treatment	NULL
,	NULL
we	NULL
investigated	NULL
immunosuppressive	NULL
agents	NULL
on	NULL
PBMC	NULL
proliferation	NULL
after	NULL
stimulation	NULL
with	NULL
influenza	NULL
virions	NULL
in	NULL
vitro	NULL
.	NULL

Various	NULL
doses	NULL
of	NULL
immunosuppressive	NULL
agents	NULL
were	NULL
administered	NULL
to	NULL
PBMC	NULL
co-cultivated	NULL
with	NULL
influenza	NULL
virion	NULL
mix	NULL
and	NULL
cell	NULL
proliferation	NULL
was	NULL
measured	NULL
after	NULL
7	NULL
days	NULL
.	NULL

Figure	NULL
1	NULL
shows	NULL
that	NULL
aspirin	NULL
and	NULL
CyA	NULL
inhibited	NULL
PBMC	NULL
proliferation	NULL
in	NULL
a	NULL
dose-dependent	NULL
fashion	NULL
,	NULL
whereas	NULL
indomethacin	NULL
had	NULL
no	NULL
suppressive	NULL
effect	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

Aspirin	NULL
at	NULL
concentrations	NULL
between	NULL
5	NULL
mM	NULL
(	NULL
0.9	NULL
mg/ml	NULL
)	NULL
and	NULL
40	NULL
mM	NULL
(	NULL
7.2	NULL
mg/ml	NULL
)	NULL
and	NULL
CyA	NULL
at	NULL
concentrations	NULL
of	NULL
100	NULL
ng/ml	NULL
and	NULL
more	NULL
inhibited	NULL
PBMC	NULL
proliferation	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
.	NULL

To	NULL
examine	NULL
interindividual	NULL
differences	NULL
in	NULL
the	NULL
PBMC	NULL
As	NULL
cpm	NULL
+	NULL
+	NULL
+	NULL
+	NULL
Influenza	NULL
mix	NULL
40	NULL
Aspirin	NULL
(	NULL
mM	NULL
)	NULL
control	NULL
PHA	NULL
o	NULL
+	NULL
an	NULL
a	NULL
C	NULL
he	NULL
o	NULL
10	NULL
?	NULL

.	NULL

+	NULL
a	NULL
Influenza	NULL
mix	NULL
control	NULL
Pria	NULL
+	NULL
+	NULL
+	NULL
+	NULL
0	NULL
1	NULL
10	NULL
100	NULL
500	NULL
1000	NULL
-	NULL
Cyclosporin	NULL
A	NULL
(	NULL
ng/m	NULL
)	NULL
+	NULL
a	NULL
+	NULL
e	NULL
+	NULL
+	NULL
Influenza	NULL
mix	NULL
200	NULL
-	NULL
2000	NULL
-	NULL
indomethacin	NULL
(	NULL
ng/m	NULL
!	NULL
)	NULL

control	NULL
PHA	NULL
o	NULL
el	NULL
ho	NULL
no	NULL
no	NULL
o	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Effects	NULL
of	NULL
immmunosuppressive/anti-inflammatory	NULL
agents	NULL
on	NULL
PBMC	NULL
proliferation	NULL
.	NULL

PBMC	NULL
were	NULL
co-cultivated	NULL
with	NULL
inactivated	NULL
intact	NULL
influenza	NULL
virions	NULL
and	NULL
various	NULL
agents	NULL
,	NULL
including	NULL
aspirin	NULL
(	NULL
A	NULL
)	NULL
,	NULL
CyA	NULL
(	NULL
B	NULL
)	NULL
,	NULL
and	NULL
indomethacin	NULL
(	NULL
C	NULL
)	NULL
,	NULL
used	NULL
in	NULL
the	NULL
indicated	NULL
concentrations	NULL
to	NULL
detect	NULL
their	NULL
effectiveness	NULL
.	NULL

Proliferation	NULL
assays	NULL
were	NULL
performed	NULL
after	NULL
7	NULL
days	NULL
.	NULL

As	NULL
a	NULL
control	NULL
,	NULL
unspecific	NULL
stimulation	NULL
of	NULL
PBMC	NULL
by	NULL
PHA	NULL
(	NULL
1	NULL
ug/ml	NULL
)	NULL
was	NULL
used	NULL
.	NULL

The	NULL
figure	NULL
shows	NULL
a	NULL
representative	NULL
example	NULL
of	NULL
1	NULL
of	NULL
15	NULL
patients	NULL
examined	NULL
(	NULL
n	NULL
=	NULL
15	NULL
,	NULL
p	NULL
<	NULL
0.05	NULL
,	NULL
SD	NULL
)	NULL
.	NULL

response	NULL
to	NULL
immunosuppressive	NULL
agents	NULL
,	NULL
15	NULL
donors	NULL
,	NULL
aged	NULL
20-35	NULL
years	NULL
,	NULL
were	NULL
analyzed	NULL
.	NULL

While	NULL
the	NULL
specific	NULL
response	NULL
of	NULL
PBMC	NULL
proliferation	NULL
to	NULL
influenza	NULL
virus	NULL
mix	NULL
stimulation	NULL
differed	NULL
among	NULL
donors	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
suppression	NULL
of	NULL
cell	NULL
proliferation	NULL
by	NULL
CyA	NULL
and	NULL
aspirin	NULL
was	NULL
comparable	NULL
.	NULL

Cell	NULL
viability	NULL
was	NULL
measured	NULL
in	NULL
parallel	NULL
cultures	NULL
on	NULL
day	NULL
7	NULL
by	NULL
propidium	NULL
iodide	NULL
(	NULL
PI	NULL
)	NULL
staining	NULL
and	NULL
FACS	NULL
analysis	NULL
.	NULL

No	NULL
increased	NULL
cell	NULL
death	NULL
was	NULL
observed	NULL
in	NULL
PBMC	NULL
cultured	NULL
in	NULL
medium	NULL
supplemented	NULL
with	NULL
immunosuppressive	NULL
agents	NULL
versus	NULL
PBMC	NULL
cultivated	NULL
in	NULL
normal	NULL
culture	NULL
medium	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Modulation	NULL
of	NULL
EC	NULL
Activation	NULL
by	NULL
Immunosuppressive	NULL
Agents	NULL
HUVEC	NULL
monolayers	NULL
were	NULL
cultivated	NULL
in	NULL
EC	NULL
medium	NULL
supplemented	NULL
with	NULL
TNF-a	NULL
and	NULL
various	NULL
A.	NULL
Amberger	NULL
et	NULL
al	NULL
.	NULL

:	NULL
Effects	NULL
of	NULL
Anti-inflammatory	NULL
Agents	NULL
on	NULL
HUVECs	NULL
121	NULL
Aspirin	NULL
(	NULL
mM	NULL
)	NULL
O0	NULL
_	NULL
O	NULL
_	NULL
5	NULL
10	NULL
20	NULL
40	NULL
5	NULL
10	NULL
20	NULL
40	NULL
TNF-	NULL
(	NULL
10	NULL
ng/miI	NULL
)	NULL
-	NULL
+	NULL
+0	NULL
+	NULL
+	NULL
+00	NULL
-	NULL
-	NULL
-	NULL
ELAM-1	NULL
ICAM-1	NULL
|	NULL
VCAM-1	NULL
MCP-1	NULL
w*	NULL
v	NULL
»	NULL
wwab	NULL
m	NULL
yi	NULL
.	NULL

%	NULL
CyA	NULL
(	NULL
ug/ml	NULL
)	NULL
0	NULL
_	NULL
O	NULL
0.5	NULL
1	NULL
10	NULL
100	NULL
0.5	NULL
1	NULL
10	NULL
100	NULL
TNF-	NULL
(	NULL
1	NULL
(	NULL
10ng/m	NULL
!	NULL

l	NULL
)	NULL
_-	NULL
+	NULL
.	NULL

ELAM-1	NULL
VCAM-1	NULL
ICAM-1	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Effects	NULL
of	NULL
various	NULL
MCP-1	NULL
8	NULL
L	NULL
agents	NULL
on	NULL
expression	NULL
m-	NULL
of	NULL
adhesion	NULL
molecules	NULL
.	NULL

GAPDH	NULL
-	NULL
waa	NULL
wo	NULL
ao	NULL
wo	NULL
aos	NULL
-	NULL
UP	NULL
H2	NULL
HUVECs	NULL
were	NULL
cultivated	NULL
in	NULL
fresh	NULL
medium	NULL
containing	NULL
the	NULL
C	NULL
indicated	NULL
concentrations	NULL
of	NULL
aspirin	NULL
(	NULL
A	NULL
)	NULL
,	NULL
CyA	NULL
(	NULL
B	NULL
)	NULL
,	NULL
and	NULL
Indomethacin	NULL
(	NULL
ug/ml	NULL
)	NULL
0	NULL
0	NULL
0.05	NULL
0.5	NULL
5	NULL
50	NULL
100	NULL
0.05	NULL
0.5	NULL
5	NULL
50	NULL
100	NULL
_	NULL
indomethacin	NULL
(	NULL
C	NULL
)	NULL
in	NULL
the	NULL
TNF-	NULL
(	NULL
4	NULL
(	NULL
10	NULL
ng/m	NULL
!	NULL

i	NULL
)	NULL
_-	NULL
+	NULL
+	NULL
*+	NULL
+	NULL
+	NULL
*+	NULL
*	NULL
*	NULL
=	NULL
*	NULL
#	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
ELAM-1	NULL
«	NULL
tp	NULL
cwew	NULL
Gp	NULL
o	NULL
~	NULL
o-	NULL
-~	NULL
TNF-a	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
for	NULL
6	NULL
hr	NULL
.	NULL

sC	NULL
Northern	NULL
blots	NULL
were	NULL
per-ICAM-1	NULL
a	NULL
mes	NULL
ah	NULL
formed	NULL
with	NULL
total	NULL
RNA	NULL
.	NULL

Only	NULL
aspirin	NULL
shows	NULL
an	NULL
inhibitory	NULL
effect	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
adhesion	NULL
molecules	NULL
.	NULL

GAPDH	NULL
was	NULL
used	NULL
to	NULL
standardize	NULL
the	NULL
RNA	NULL
amount	NULL
.	NULL

The	NULL
autoradio-	NULL
Coe	NULL
wees	NULL
ﬂ	NULL
a	NULL
q	NULL
graph	NULL
is	NULL
a	NULL
representative	NULL
ex	NULL
ample	NULL
of	NULL
three	NULL
experiments	NULL
.	NULL

VCAM-1	NULL
MCP-1	NULL
GAPDH	NULL
concentrations	NULL
of	NULL
immunosuppressive	NULL
,	NULL
anti-in-	NULL
take	NULL
of	NULL
immunosuppressive	NULL
agents	NULL
and	NULL
con-flammatory	NULL
agents	NULL
,	NULL
or	NULL
in	NULL
medium	NULL
supple-	NULL
centrate	NULL
them	NULL
at	NULL
distinct	NULL
sites	NULL
,	NULL
we	NULL
also	NULL
tested	NULL
mented	NULL
with	NULL
immunosuppressive	NULL
agents	NULL
alone	NULL
.	NULL

high	NULL
concentrations	NULL
of	NULL
indomethacin	NULL
and	NULL
CyA	NULL
.	NULL

Figure	NULL
2	NULL
demonstrates	NULL
that	NULL
TNF-a	NULL
induced	NULL
ex-	NULL
As	NULL
shown	NULL
in	NULL
Figure	NULL
2	NULL
B	NULL
,	NULL
C	NULL
,	NULL
concentrations	NULL
as	NULL
pression	NULL
of	NULL
adhesion	NULL
molecules	NULL
ICAM-1	NULL
,	NULL
high	NULL
as	NULL
100	NULL
mg/ml	NULL
of	NULL
CyA	NULL
or	NULL
indomethacin	NULL
VCAM-1	NULL
,	NULL
ELAM-1	NULL
,	NULL
and	NULL
the	NULL
chemoattractant	NULL
(	NULL
except	NULL
at	NULL
the	NULL
highest	NULL
concentration	NULL
)	NULL
failed	NULL
to	NULL
protein	NULL
MCP-1	NULL
.	NULL

This	NULL
induction	NULL
was	NULL
constantly	NULL
suppress	NULL
induction	NULL
of	NULL
adhesion	NULL
molecules	NULL
and	NULL
suppressed	NULL
by	NULL
concentrations	NULL
of	NULL
aspirin	NULL
be-	NULL
MCP-1	NULL
expression	NULL
by	NULL
TNF-a	NULL
«	NULL
,	NULL
and	NULL
were	NULL
not	NULL
tween	NULL
5	NULL
and	NULL
40	NULL
mM	NULL
(	NULL
0.9	NULL
mg/ml-7.2	NULL
mg/ml	NULL
)	NULL
effective	NULL
in	NULL
inducing	NULL
adhesion	NULL
molecules	NULL
or	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
CyA	NULL
and	NULL
indomethacin	NULL
MCP-1	NULL
.	NULL

EC	NULL
viability	NULL
during	NULL
experiments	NULL
with	NULL
did	NULL
not	NULL
suppress	NULL
induction	NULL
of	NULL
adhesion	NULL
mole-	NULL
anti-inflammatory	NULL
agents	NULL
was	NULL
analyzed	NULL
by	NULL
de-cules	NULL
and	NULL
MCP-1	NULL
by	NULL
TNF-a	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
C	NULL
)	NULL
.	NULL

None	NULL
termination	NULL
of	NULL
apoptosis	NULL
by	NULL
PI	NULL
staining	NULL
of	NULL
nu-of	NULL
the	NULL
immunosuppressive	NULL
agents	NULL
alone	NULL
in-	NULL
clei	NULL
followed	NULL
by	NULL
flow	NULL
cytometry	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Apoptosis	NULL
duced	NULL
adhesion	NULL
molecules	NULL
or	NULL
MCP-1	NULL
in	NULL
EC	NULL
.	NULL

was	NULL
not	NULL
significantly	NULL
increased	NULL
in	NULL
EC	NULL
cultivated	NULL
in	NULL
Since	NULL
local	NULL
conditions	NULL
in	NULL
vivo	NULL
could	NULL
favor	NULL
up-	NULL
medium	NULL
supplemented	NULL
for	NULL
6	NULL
hr	NULL
with	NULL
anti-inflam-	NULL
122	NULL
Molecular	NULL
Medicine	NULL
,	NULL
Volume	NULL
5	NULL
,	NULL
Number	NULL
2	NULL
,	NULL
February	NULL
1999	NULL
A	NULL
Aspirin	NULL
(	NULL
mM	NULL
)	NULL
0	NULL
_	NULL
5	NULL
10	NULL
20	NULL
40	NULL
Hsp	NULL
60	NULL
i	NULL
Wi	NULL
Hsp	NULL
70	NULL
B-Actin	NULL
CyA	NULL
(	NULL
ng/ml	NULL
)	NULL
0	NULL
1	NULL
10	NULL
100	NULL
500	NULL
1000	NULL
H.S	NULL
.	NULL

HSp	NULL
60	NULL
|a	NULL
Wangm	NULL
Hsp	NULL
70	NULL
1	NULL
ean	NULL
B-Actin	NULL
|i	NULL
C	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Induction	NULL
of	NULL
Hsp	NULL
expression	NULL
.	NULL

HUVECs	NULL
were	NULL
treated	NULL
with	NULL
the	NULL
immunosuppressive/anti-inflammatory	NULL
agents	NULL
aspirin	NULL
(	NULL
A	NULL
)	NULL
,	NULL
CyA	NULL
(	NULL
B	NULL
)	NULL
,	NULL
and	NULL
50	NULL
100	NULL
_	NULL
indomethacin	NULL
(	NULL
C	NULL
)	NULL
at	NULL
the	NULL
indicated	NULL
concentra-	NULL
Indomethacin	NULL
(	NULL
ug/ml	NULL
)	NULL
O0	NULL
0.05	NULL
0.5	NULL
1	NULL
5	NULL
Hsp	NULL
60	NULL
tions	NULL
for	NULL
6	NULL
hr	NULL
and	NULL
total	NULL
RNA	NULL
was	NULL
isolated	NULL
according	NULL
to	NULL
standard	NULL
protocol	NULL
.	NULL

Northern	NULL
blots	NULL
Hsp	NULL
70	NULL
B-Actin	NULL
matory	NULL
agents	NULL
,	NULL
even	NULL
at	NULL
high	NULL
doses	NULL
,	NULL
compared	NULL
to	NULL
EC	NULL
cultivated	NULL
in	NULL
medium	NULL
alone	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Induction	NULL
of	NULL
Heat	NULL
Shock	NULL
Proteins	NULL
in	NULL
HUVECs	NULL
by	NULL
Aspirin	NULL
,	NULL
CyA	NULL
,	NULL
and	NULL
Indomethacin	NULL
The	NULL
same	NULL
preparations	NULL
of	NULL
HUVECs	NULL
were	NULL
used	NULL
in	NULL
parallel	NULL
studies	NULL
to	NULL
examine	NULL
the	NULL
ability	NULL
of	NULL
immunosuppressive	NULL
agents	NULL
to	NULL
induce	NULL
Hsp60	NULL
and	NULL
Hsp70	NULL
expression	NULL
.	NULL

Results	NULL
of	NULL
a	NULL
first	NULL
series	NULL
of	NULL
experiments	NULL
confirmed	NULL
earlier	NULL
studies	NULL
from	NULL
our	NULL
laboratory	NULL
:	NULL
TNF-a	NULL
alone	NULL
is	NULL
a	NULL
potent	NULL
inducer	NULL
of	NULL
Hsp60	NULL
expression	NULL
in	NULL
endothelial	NULL
cells	NULL
(	NULL
20	NULL
)	NULL
.	NULL

We	NULL
then	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
immunosuppressive	NULL
agents	NULL
on	NULL
EC	NULL
without	NULL
addition	NULL
of	NULL
TNF-a	NULL
to	NULL
the	NULL
culture	NULL
medium	NULL
.	NULL

Figure	NULL
3	NULL
shows	NULL
that	NULL
Hsp60	NULL
mRNA	NULL
was	NULL
slightly	NULL
expressed	NULL
in	NULL
EC	NULL
under	NULL
normal-cer-tainly	NULL
also	NULL
somewhat	NULL
stressful-	NULL
culture	NULL
condi-tions	NULL
.	NULL

Aspirin	NULL
concentrations	NULL
of	NULL
5	NULL
to	NULL
40	NULL
mM	NULL
induced	NULL
expression	NULL
of	NULL
Hsp60	NULL
mRNA	NULL
compared	NULL
to	NULL
untreated	NULL
control	NULL
cells	NULL
.	NULL

Furthermore	NULL
,	NULL
aspirin	NULL
induced	NULL
expression	NULL
of	NULL
Hsp70	NULL
mRNA	NULL
only	NULL
at	NULL
high	NULL
concentrations	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

CyA	NULL
in	NULL
concentrations	NULL
from	NULL
100	NULL
ng/ml	NULL
to	NULL
1000	NULL
ng/m	NULL
!	NULL

induced	NULL
the	NULL
expression	NULL
of	NULL
Hsp60	NULL
mRNA	NULL
compared	NULL
to	NULL
untreated	NULL
control	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
Hsp70	NULL
expression	NULL
was	NULL
were	NULL
performed	NULL
to	NULL
detect	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
various	NULL
agents	NULL
on	NULL
Hsp	NULL
expression	NULL
.	NULL

B-actin	NULL
was	NULL
used	NULL
to	NULL
standardize	NULL
the	NULL
RNA	NULL
amount	NULL
.	NULL

The	NULL
autoradio-graph	NULL
shows	NULL
a	NULL
representative	NULL
example	NULL
of	NULL
three	NULL
experiments	NULL
.	NULL

not	NULL
induced	NULL
by	NULL
CyA	NULL
in	NULL
EC	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
3C	NULL
,	NULL
indomethacin	NULL
induced	NULL
both	NULL
Hsp60	NULL
and	NULL
Hsp70	NULL
mRNA	NULL
at	NULL
high	NULL
doses	NULL
(	NULL
100	NULL
ug/ml	NULL
)	NULL
.	NULL

This	NULL
concentration	NULL
may	NULL
be	NULL
reached	NULL
at	NULL
sites	NULL
of	NULL
favored	NULL
uptake	NULL
.	NULL

Since	NULL
the	NULL
indomethacin	NULL
stock	NULL
solution	NULL
was	NULL
dissolved	NULL
in	NULL
DMSO	NULL
,	NULL
we	NULL
also	NULL
tested	NULL
the	NULL
ability	NULL
of	NULL
DMSO	NULL
alone	NULL
to	NULL
induce	NULL
Hsp	NULL
expression	NULL
in	NULL
EC	NULL
.	NULL

DMSO	NULL
was	NULL
diluted	NULL
in	NULL
EC	NULL
medium	NULL
and	NULL
applied	NULL
to	NULL
EC	NULL
for	NULL
6	NULL
hr	NULL
.	NULL

Hsp	NULL
60	NULL
and	NULL
Hsp	NULL
70	NULL
mRNA	NULL
trancription	NULL
was	NULL
not	NULL
significantly	NULL
induced	NULL
by	NULL
DMSO	NULL
alone	NULL
in	NULL
the	NULL
same	NULL
concentration	NULL
as	NULL
that	NULL
needed	NULL
for	NULL
application	NULL
of	NULL
100	NULL
ug/ml	NULL
indomethacin	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Effects	NULL
of	NULL
Immunosuppressive	NULL
Agents	NULL
on	NULL
Transcription	NULL
Factor	NULL
Activation	NULL
The	NULL
modulation	NULL
of	NULL
HSF-1	NULL
and	NULL
NF-KB	NULL
activity	NULL
by	NULL
immunosuppressive	NULL
agents	NULL
was	NULL
assessed	NULL
in	NULL
different	NULL
preparations	NULL
of	NULL
HUVECs	NULL
.	NULL

Nuclear	NULL
protein	NULL
extracts	NULL
from	NULL
EC	NULL
treated	NULL
with	NULL
immunosuppressive	NULL
agent	NULL
were	NULL
isolated	NULL
and	NULL
incubated	NULL
with	NULL
labeled	NULL
oligonuclotides	NULL
containing	NULL
the	NULL
DNA-bind-ing	NULL
sequences	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
HSF-1	NULL
,	NULL
respectively	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
4B	NULL
,	NULL
CyA	NULL
,	NULL
aspirin	NULL
,	NULL
and	NULL
indomethacin	NULL
themselves	NULL
did	NULL
not	NULL
induce	NULL
NF-KB	NULL
ac	NULL
A.	NULL
Amberger	NULL
et	NULL
al	NULL
.	NULL

:	NULL
Effects	NULL
of	NULL
Anti-inflammatory	NULL
Agents	NULL
on	NULL
HUVECs	NULL
A	NULL
Indomethacin	NULL
-	NULL
Aspirin	NULL
(	NULL
ug/m	NULL
!	NULL
)	NULL

(	NULL
mM	NULL
)	NULL
2	NULL
y	NULL
T	NULL
w	NULL
o	NULL
o	NULL
w	NULL
eT	NULL
``	NULL
oes	NULL
2	NULL
2	NULL
0	NULL
06	NULL
0	NULL
i	NULL
m	NULL
-	NULL
in	NULL
-	NULL
A4	NULL
06	NULL
o	NULL
B	NULL
Indomethacin	NULL
-	NULL
Aspirin	NULL
(	NULL
g/m	NULL
!	NULL
)	NULL

(	NULL
mM	NULL
)	NULL
C	NULL
e	NULL
-	NULL
w	NULL
o	NULL
w	NULL
5	NULL
9	NULL
n	NULL
_	NULL
o	NULL
S	NULL
o	NULL
o	NULL
0	NULL
0	NULL
O	NULL
i	NULL
)	NULL
U	NULL
)	NULL
-	NULL
0	NULL
O	NULL
o	NULL
o	NULL
o	NULL
U	NULL
~	NULL
No	NULL
om	NULL
tivity	NULL
in	NULL
EC	NULL
.	NULL

However	NULL
,	NULL
high	NULL
concentrations	NULL
of	NULL
aspirin	NULL
(	NULL
40	NULL
mM	NULL
;	NULL
7.2	NULL
mg/ml	NULL
)	NULL
,	NULL
indomethacin	NULL
(	NULL
40	NULL
mg/ml	NULL
)	NULL
,	NULL
and	NULL
heat	NULL
shock	NULL
(	NULL
42°C	NULL
for	NULL
30	NULL
min	NULL
}	NULL
,	NULL
but	NULL
not	NULL
CyA	NULL
,	NULL
induced	NULL
HSF-1	NULL
binding	NULL
of	NULL
EC	NULL
nuclear	NULL
protein	NULL
extracts	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

TNF-a	NULL
&	NULL
-induced	NULL
NF-KB	NULL
activity	NULL
in	NULL
EC	NULL
is	NULL
suppressed	NULL
by	NULL
aspirin	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
,	NULL
but	NULL
not	NULL
by	NULL
indomethacin	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
or	NULL
CyA	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
.	NULL

The	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
was	NULL
observed	NULL
by	NULL
treatment	NULL
with	NULL
concentrations	NULL
of	NULL
aspirin	NULL
ranging	NULL
from	NULL
10	NULL
to	NULL
40	NULL
mM	NULL
(	NULL
1.8	NULL
mg/ml-7.2	NULL
mg/ml	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
the	NULL
shown	NULL
NF-KB	NULL
binding	NULL
was	NULL
confirmed	NULL
by	NULL
competition	NULL
with	NULL
a	NULL
50-fold	NULL
excess	NULL
of	NULL
cold	NULL
NF-KB	NULL
,	NULL
a	NULL
supershift	NULL
using	NULL
an	NULL
anti-NF-	NULL
«	NULL
B	NULL
antibody	NULL
,	NULL
and	NULL
by	NULL
using	NULL
a	NULL
50-fold	NULL
excess	NULL
of	NULL
cold	NULL
HSE	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

.	NULL

-	NULL
in	NULL
o	NULL
o	NULL
~	NULL
i	NULL
-	NULL
't	NULL
0	NULL
O	NULL
Cyclosporin	NULL
A	NULL
(	NULL
“	NULL
g/ml	NULL
)	NULL
oO	NULL
l=	NULL
]	NULL
spm	NULL
100	NULL
123	NULL
|	NULL
HSF-1	NULL
Cyclosporin	NULL
A	NULL
(	NULL
g/m	NULL
!	NULL
)	NULL

100	NULL
TNF	NULL
a	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Effects	NULL
of	NULL
immunosup-pressive/anti-inflammatory	NULL
agents	NULL
on	NULL
transcription	NULL
factor	NULL
activation	NULL
.	NULL

HUVECs	NULL
were	NULL
treated	NULL
with	NULL
various	NULL
immunosuppressive	NULL
agents	NULL
at	NULL
the	NULL
indicated	NULL
concentrations	NULL
and	NULL
nucleic	NULL
protein	NULL
was	NULL
extracted	NULL
according	NULL
to	NULL
the	NULL
protocol	NULL
.	NULL

For	NULL
the	NULL
EMSA	NULL
,	NULL
5	NULL
ug	NULL
of	NULL
the	NULL
nucleic	NULL
protein	NULL
was	NULL
incubated	NULL
with	NULL
1	NULL
ng	NULL
of	NULL
a	NULL
radioactively	NULL
labeled	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
sequence	NULL
(	NULL
B	NULL
)	NULL
or	NULL
the	NULL
HSF	NULL
binding	NULL
sequence	NULL
(	NULL
A	NULL
)	NULL
.	NULL

|	NULL
NF-KB	NULL
Discussion	NULL
In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
have	NULL
demonstrated	NULL
that	NULL
the	NULL
action	NULL
of	NULL
immunosuppressive	NULL
and	NULL
anti-inflammatory	NULL
agents	NULL
such	NULL
as	NULL
CyA	NULL
,	NULL
aspirin	NULL
,	NULL
and	NULL
indomethacin	NULL
,	NULL
differs	NULL
with	NULL
respect	NULL
to	NULL
suppression	NULL
of	NULL
specific	NULL
lymphocyte	NULL
responses	NULL
to	NULL
antigen	NULL
and	NULL
their	NULL
effect	NULL
on	NULL
ICAM-1	NULL
,	NULL
VCAM-1	NULL
,	NULL
ELAM-1	NULL
,	NULL
and	NULL
MCP-1	NULL
expression	NULL
on	NULL
activated	NULL
endothelial	NULL
cells	NULL
in	NULL
vitro	NULL
.	NULL

Importantly	NULL
,	NULL
we	NULL
have	NULL
also	NULL
shown	NULL
that	NULL
CyA	NULL
and	NULL
aspirin	NULL
can	NULL
induce	NULL
Hsps	NULL
.	NULL

CyA	NULL
blocks	NULL
early	NULL
events	NULL
in	NULL
antigen	NULL
recognition	NULL
and	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
by	NULL
binding	NULL
to	NULL
cyclo-philin	NULL
and	NULL
subsequent	NULL
prevention	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
IL-2	NULL
.	NULL

However	NULL
,	NULL
CyA	NULL
is	NULL
less	NULL
effective	NULL
in	NULL
0	NULL
0.05	NULL
0.5	NULL
1	NULL
5	NULL
+o	NULL
+0	NULL
+	NULL
+	NULL
124	NULL
Molecular	NULL
Medicine	NULL
,	NULL
Volume	NULL
5	NULL
,	NULL
Number	NULL
2	NULL
,	NULL
February	NULL
1999	NULL
A	NULL
B	NULL
Aspirin	NULL
(	NULL
mM	NULL
)	NULL
0	NULL
0	NULL
1	NULL
5	NULL
10	NULL
20	NULL
40	NULL
-	NULL
Indomethacin	NULL
(	NULL
g/m	NULL
!	NULL
)	NULL

0	NULL
TNF	NULL
(	NULL
10ng/m	NULL
!	NULL
)	NULL

600	NULL
%	NULL
o	NULL
4	NULL
&	NULL
0	NULL
o	NULL
$	NULL
#	NULL
oo	NULL
+	NULL
TNFa	NULL
(	NULL
10ng/m	NULL
!	NULL
)	NULL

k	NULL
NFB	NULL
C	NULL
CyA	NULL
(	NULL
ng/m	NULL
!	NULL
)	NULL

0	NULL
0	NULL
TNF	NULL
.	NULL

(	NULL
10ng/m	NULL
!	NULL
)	NULL

*	NULL
NFB	NULL
blocking	NULL
responses	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
to	NULL
presentation	NULL
of	NULL
antigen	NULL
(	NULL
31	NULL
)	NULL
.	NULL

Since	NULL
CyA	NULL
is	NULL
an	NULL
effective	NULL
suppressor	NULL
of	NULL
T	NULL
cell	NULL
activation	NULL
,	NULL
it	NULL
was	NULL
used	NULL
as	NULL
a	NULL
possible	NULL
tool	NULL
to	NULL
examine	NULL
the	NULL
role	NULL
of	NULL
T	NULL
cells	NULL
in	NULL
atherogenesis	NULL
.	NULL

Surprisingly	NULL
,	NULL
it	NULL
was	NULL
shown	NULL
that	NULL
CyA	NULL
administration	NULL
was	NULL
associated	NULL
with	NULL
an	NULL
increased	NULL
severity	NULL
of	NULL
atherosclerosis	NULL
in	NULL
cholesterol-fed	NULL
rabbits	NULL
(	NULL
21	NULL
)	NULL
and	NULL
mice	NULL
given	NULL
an	NULL
atherogenic	NULL
diet	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Although	NULL
administration	NULL
of	NULL
CyA	NULL
resulted	NULL
in	NULL
suppression	NULL
of	NULL
cell-mediated	NULL
immunity	NULL
,	NULL
no	NULL
gross	NULL
changes	NULL
in	NULL
the	NULL
number	NULL
of	NULL
lymphocytes	NULL
1	NULL
10	NULL
100	NULL
500	NULL
1000	NULL
+o	NULL
to	NULL
+	NULL
+	NULL
4+	NULL
+	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Effects	NULL
of	NULL
immu-nosuppressive/anti-in-	NULL
agents	NULL
on	NULL
activated	NULL
transcription	NULL
factor	NULL
NF-KB	NULL
.	NULL

Endothelial	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
TNF-a	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
to	NULL
activate	NULL
the	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
with	NULL
the	NULL
various	NULL
concentrations	NULL
of	NULL
the	NULL
respective	NULL
agents	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Only	NULL
aspirin	NULL
(	NULL
A	NULL
)	NULL
showed	NULL
an	NULL
inhibitory	NULL
effect	NULL
on	NULL
the	NULL
activation	NULL
of	NULL
NF-kB	NULL
,	NULL
whereas	NULL
indomethacin	NULL
(	NULL
B	NULL
)	NULL
and	NULL
CyA	NULL
(	NULL
C	NULL
)	NULL
had	NULL
no	NULL
effect	NULL
.	NULL

within	NULL
atherosclerotic	NULL
lesions	NULL
was	NULL
observed	NULL
in	NULL
these	NULL
rabbits	NULL
.	NULL

Emeson	NULL
and	NULL
Shen	NULL
suggested	NULL
that	NULL
this	NULL
result	NULL
was	NULL
due	NULL
to	NULL
increased	NULL
low-density	NULL
li-poprotein	NULL
(	NULL
LDL	NULL
)	NULL
cholesterol	NULL
by	NULL
CyA	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Studies	NULL
by	NULL
Roselaar	NULL
et	NULL
al	NULL
.	NULL

(	NULL
21	NULL
)	NULL
gave	NULL
similar	NULL
results	NULL
in	NULL
CyA-treated	NULL
rabbits	NULL
,	NULL
but	NULL
they	NULL
did	NULL
not	NULL
observe	NULL
any	NULL
changes	NULL
in	NULL
LDL	NULL
metabolism	NULL
.	NULL

These	NULL
authors	NULL
discussed	NULL
the	NULL
possibility	NULL
that	NULL
atherosclerosis	NULL
in	NULL
these	NULL
mice	NULL
developed	NULL
through	NULL
changes	NULL
in	NULL
specific	NULL
cytokine-mediated	NULL
effects	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Based	NULL
on	NULL
previous	NULL
observations	NULL
from	NULL
our	NULL
laboratory	NULL
,	NULL
we	NULL
hy-	NULL
A.	NULL
Amberger	NULL
et	NULL
al	NULL
.	NULL

:	NULL
Effects	NULL
of	NULL
Anti-inflammatory	NULL
Agents	NULL
on	NULL
HUVECs	NULL
125	NULL
TNFa	NULL
NFB	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

Specifity	NULL
of	NULL
NF-	NULL
«	NULL
B-binding	NULL
activity	NULL
in	NULL
endothelial	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
TNF-	NULL
«	NULL
@	NULL
.	NULL

Nuclear	NULL
proteins	NULL
of	NULL
endothelial	NULL
cells	NULL
treated	NULL
with	NULL
TNF-a	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
for	NULL
30	NULL
min	NULL
were	NULL
incubated	NULL
with	NULL
°	NULL
>	NULL
P-labeled	NULL
NF-	NULL
«	NULL
B	NULL
oligonucleotide	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
unlabeled	NULL
oligonucleotide	NULL
containing	NULL
NF-	NULL
«	NULL
B	NULL
or	NULL
HSE	NULL
binding	NULL
element	NULL
(	NULL
cold	NULL
oligonucleotide	NULL
)	NULL
.	NULL

Incubation	NULL
with	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
antibody	NULL
led	NULL
to	NULL
a	NULL
supershifted	NULL
DNA-binding	NULL
complex	NULL
.	NULL

pothesize	NULL
that	NULL
recruitment	NULL
of	NULL
Hsp65/60-reactive	NULL
T	NULL
cells	NULL
into	NULL
the	NULL
intima	NULL
is	NULL
a	NULL
crucial	NULL
step	NULL
in	NULL
the	NULL
initiation	NULL
of	NULL
atherosclerosis	NULL
,	NULL
and	NULL
that	NULL
sensitization	NULL
of	NULL
these	NULL
T	NULL
cells	NULL
probably	NULL
occurs	NULL
at	NULL
more	NULL
distant	NULL
sites	NULL
,	NULL
such	NULL
as	NULL
draining	NULL
lymph	NULL
nodes	NULL
(	NULL
6,7	NULL
)	NULL
.	NULL

Adhesion	NULL
molecule	NULL
and	NULL
MCP-1	NULL
expression	NULL
by	NULL
endothelial	NULL
cells	NULL
are	NULL
necessary	NULL
for	NULL
recruitment	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
into	NULL
the	NULL
arterial	NULL
intima	NULL
because	NULL
of	NULL
the	NULL
relatively	NULL
low	NULL
binding	NULL
affinity	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
to	NULL
its	NULL
antigen	NULL
.	NULL

For	NULL
the	NULL
initiation	NULL
of	NULL
the	NULL
immune	NULL
response	NULL
in	NULL
atherosclerosis	NULL
a	NULL
fine	NULL
balance	NULL
between	NULL
the	NULL
adhesion	NULL
molecule	NULL
and	NULL
the	NULL
Hsp60	NULL
surface	NULL
expression	NULL
seems	NULL
to	NULL
be	NULL
required	NULL
.	NULL

Hsp60-reactive	NULL
T	NULL
cells	NULL
could	NULL
show	NULL
prolonged	NULL
adherence	NULL
to	NULL
stressed	NULL
,	NULL
adhesion	NULL
molecule-express-ing	NULL
endothelial	NULL
cells	NULL
,	NULL
recognizing	NULL
Hsp60	NULL
and	NULL
thus	NULL
evoking	NULL
endothelial	NULL
injury	NULL
via	NULL
cell-mediated	NULL
cy-totoxicity	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
this	NULL
study	NULL
,	NULL
CyA	NULL
is	NULL
not	NULL
effective	NULL
in	NULL
suppressing	NULL
adhesion	NULL
molecule	NULL
and	NULL
MCP-1	NULL
expression	NULL
after	NULL
induction	NULL
by	NULL
TNF-	NULL
«	NULL
.	NULL

This	NULL
lack	NULL
of	NULL
suppression	NULL
of	NULL
adhesion	NULL
molecule	NULL
and	NULL
MCP-1	NULL
expression	NULL
by	NULL
CyA	NULL
may	NULL
be	NULL
partially	NULL
explained	NULL
by	NULL
the	NULL
inability	NULL
to	NULL
inactivate	NULL
the	NULL
transcription	NULL
factor	NULL
NF-KB	NULL
in	NULL
EC	NULL
.	NULL

Cockerill	NULL
et	NULL
al	NULL
.	NULL

demonstrated	NULL
that	NULL
CyA	NULL
can	NULL
inhibit	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
and	NULL
ELAM-1	NULL
expression	NULL
in	NULL
endothelial	NULL
cells	NULL
(	NULL
32	NULL
)	NULL
.	NULL

This	NULL
controversial	NULL
observation	NULL
could	NULL
be	NULL
due	NULL
to	NULL
the	NULL
fact	NULL
that	NULL
in	NULL
their	NULL
study	NULL
they	NULL
added	NULL
CyA	NULL
10	NULL
min	NULL
before	NULL
stimulation	NULL
of	NULL
adhesion	NULL
molecule	NULL
expression	NULL
by	NULL
TNF-a	NULL
and	NULL
interferon	NULL
y	NULL
(	NULL
IFN-y	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
inhibition	NULL
of	NULL
ELAM-1	NULL
expression	NULL
was	NULL
40	NULL
%	NULL
compared	NULL
to	NULL
that	NULL
of	NULL
the	NULL
control	NULL
,	NULL
which	NULL
may	NULL
not	NULL
be	NULL
sufficient	NULL
to	NULL
inhibit	NULL
the	NULL
recruitment	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

More	NULL
importantly	NULL
,	NULL
CyA	NULL
emerged	NULL
as	NULL
an	NULL
inducer	NULL
of	NULL
Hsp60	NULL
in	NULL
human	NULL
EC	NULL
at	NULL
concentrations	NULL
sufficient	NULL
to	NULL
suppress	NULL
antigen-specific	NULL
T	NULL
cell	NULL
proliferation	NULL
in	NULL
vitro	NULL
(	NULL
Figs	NULL
.	NULL

1	NULL
and	NULL
3B	NULL
)	NULL
and	NULL
T	NULL
cell	NULL
immunity	NULL
to	NULL
allogenic	NULL
skin	NULL
grafts	NULL
in	NULL
vivo	NULL
(	NULL
21	NULL
)	NULL
.	NULL

We	NULL
suggest	NULL
,	NULL
therefore	NULL
,	NULL
that	NULL
the	NULL
enhancement	NULL
of	NULL
atherosclerosis	NULL
in	NULL
cholesterol-fed	NULL
rabbits	NULL
and	NULL
mice	NULL
(	NULL
21,22	NULL
)	NULL
is	NULL
due	NULL
to	NULL
induction	NULL
of	NULL
Hsp60	NULL
by	NULL
EC	NULL
.	NULL

Since	NULL
the	NULL
immunosuppressive	NULL
effect	NULL
of	NULL
CyA	NULL
is	NULL
most	NULL
prominent	NULL
during	NULL
the	NULL
induction	NULL
phase	NULL
of	NULL
a	NULL
T	NULL
cell	NULL
response	NULL
,	NULL
and	NULL
less	NULL
so	NULL
in	NULL
Hsp6O-reactive	NULL
memory	NULL
cells	NULL
,	NULL
the	NULL
Hsp60	NULL
and	NULL
adhesion	NULL
molecule-inducing	NULL
effect	NULL
obviously	NULL
overrides	NULL
the	NULL
former	NULL
,	NULL
although	NULL
the	NULL
mechanism	NULL
of	NULL
induction	NULL
is	NULL
not	NULL
known	NULL
.	NULL

The	NULL
promotor	NULL
region	NULL
of	NULL
the	NULL
human	NULL
Hsp60	NULL
gene	NULL
remains	NULL
to	NULL
be	NULL
cloned	NULL
and	NULL
analyzed	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
is	NULL
difficult	NULL
to	NULL
define	NULL
the	NULL
transcription	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
responsible	NULL
for	NULL
CyA	NULL
-induced	NULL
Hsp60	NULL
expression	NULL
.	NULL

We	NULL
found	NULL
that	NULL
CyA	NULL
did	NULL
not	NULL
induce	NULL
HSF-1	NULL
in	NULL
EC	NULL
,	NULL
as	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
necessary	NULL
for	NULL
Hsp70	NULL
gene	NULL
expression	NULL
in	NULL
many	NULL
different	NULL
cell	NULL
types	NULL
(	NULL
33	NULL
)	NULL
.	NULL

More	NULL
recently	NULL
,	NULL
Drew	NULL
and	NULL
Tipping	NULL
demonstrated	NULL
that	NULL
CyA	NULL
treatment	NULL
reduces	NULL
atherosclerosis	NULL
in	NULL
cholesterol-fed	NULL
rabbits	NULL
(	NULL
34	NULL
)	NULL
.	NULL

The	NULL
authors	NULL
showed	NULL
that	NULL
no	NULL
CD4	NULL
*	NULL
cells	NULL
could	NULL
be	NULL
detected	NULL
in	NULL
the	NULL
few	NULL
plaques	NULL
of	NULL
CyA-treated	NULL
animals	NULL
,	NULL
whereas	NULL
circulating	NULL
T	NULL
cell	NULL
numbers	NULL
and	NULL
subsets	NULL
were	NULL
un-affected	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
rabbits	NULL
were	NULL
analyzed	NULL
4	NULL
weeks	NULL
after	NULL
starting	NULL
the	NULL
cholesterol-rich	NULL
diet	NULL
compared	NULL
to	NULL
studies	NULL
by	NULL
others	NULL
in	NULL
which	NULL
lesions	NULL
developed	NULL
over	NULL
periods	NULL
of	NULL
4-8	NULL
months	NULL
(	NULL
21	NULL
)	NULL
.	NULL

It	NULL
is	NULL
tempting	NULL
to	NULL
suggest	NULL
that	NULL
,	NULL
in	NULL
CyA-treated	NULL
animals	NULL
,	NULL
lesion	NULL
formation	NULL
might	NULL
be	NULL
delayed	NULL
,	NULL
but	NULL
not	NULL
in-hibited	NULL
.	NULL

Aspirin	NULL
and	NULL
indomethacin	NULL
belong	NULL
to	NULL
a	NULL
class	NULL
of	NULL
nonsteroidal	NULL
anti-inflammatory	NULL
drugs	NULL
,	NULL
and	NULL
as	NULL
126	NULL
Molecular	NULL
Medicine	NULL
,	NULL
Volume	NULL
5	NULL
,	NULL
Number	NULL
2	NULL
,	NULL
February	NULL
1999	NULL
pirin	NULL
is	NULL
commonly	NULL
used	NULL
to	NULL
treat	NULL
certain	NULL
symptoms	NULL
of	NULL
inflammatory	NULL
and	NULL
cardiovascular	NULL
dis-eases	NULL
.	NULL

Recently	NULL
,	NULL
it	NULL
was	NULL
shown	NULL
that	NULL
aspirin	NULL
treatment	NULL
of	NULL
clinically	NULL
apparently	NULL
healthy	NULL
men	NULL
with	NULL
high	NULL
base-line	NULL
C-reactive	NULL
protein	NULL
serum	NULL
levels	NULL
was	NULL
associated	NULL
with	NULL
a	NULL
decreased	NULL
risk	NULL
for	NULL
a	NULL
first	NULL
myocardial	NULL
infarction	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
anti-inflammatory	NULL
effect	NULL
of	NULL
aspirin	NULL
may	NULL
have	NULL
clinical	NULL
benefits	NULL
in	NULL
preventing	NULL
cardiovascular	NULL
disease	NULL
,	NULL
(	NULL
23	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
its	NULL
use	NULL
in	NULL
preventing	NULL
atherosclerosis	NULL
,	NULL
higher	NULL
doses	NULL
of	NULL
aspirin	NULL
are	NULL
necessary	NULL
to	NULL
treat	NULL
inflammatory	NULL
diseases	NULL
(	NULL
35	NULL
)	NULL
.	NULL

Recent	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
high	NULL
doses	NULL
of	NULL
aspirin	NULL
inhibit	NULL
the	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
by	NULL
preventing	NULL
inhibitor-kB	NULL
degradation	NULL
,	NULL
which	NULL
is	NULL
necessary	NULL
for	NULL
release	NULL
and	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
from	NULL
the	NULL
inactive	NULL
cytoplasmic	NULL
complex	NULL
(	NULL
25,26	NULL
,	NULL
36	NULL
)	NULL
.	NULL

Suppression	NULL
of	NULL
NF-KB	NULL
activation	NULL
correlates	NULL
with	NULL
decreased	NULL
adhesion	NULL
molecule	NULL
and	NULL
MCP-1	NULL
expression	NULL
by	NULL
anti-inflammatory	NULL
agents	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

High	NULL
doses	NULL
of	NULL
aspirin	NULL
(	NULL
from	NULL
10	NULL
to	NULL
40	NULL
mM	NULL
;	NULL
1.8	NULL
mg/ml	NULL
to	NULL
7.2	NULL
mg/ml	NULL
)	NULL
may	NULL
be	NULL
observed	NULL
in	NULL
vivo	NULL
because	NULL
the	NULL
local	NULL
conditions	NULL
may	NULL
favor	NULL
its	NULL
uptake	NULL
and	NULL
concentration	NULL
,	NULL
possibly	NULL
enhancing	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
at	NULL
these	NULL
sites	NULL
(	NULL
37	NULL
)	NULL
.	NULL

In	NULL
the	NULL
current	NULL
study	NULL
,	NULL
we	NULL
demonstrated	NULL
that	NULL
doses	NULL
of	NULL
aspirin	NULL
that	NULL
effectively	NULL
suppress	NULL
adhesion	NULL
molecule	NULL
and	NULL
MCP-1	NULL
expression	NULL
also	NULL
effectively	NULL
induce	NULL
Hsp60	NULL
and	NULL
Hsp70	NULL
.	NULL

Hsp70	NULL
expression	NULL
induced	NULL
by	NULL
aspirin	NULL
correlates	NULL
with	NULL
HSF-1	NULL
activity	NULL
in	NULL
endothelial	NULL
cells	NULL
,	NULL
suggesting	NULL
that	NULL
HSF-1	NULL
is	NULL
involved	NULL
in	NULL
aspirin-induced	NULL
Hsp70	NULL
expression	NULL
.	NULL

Jurivich	NULL
et	NULL
al	NULL
.	NULL

(	NULL
38	NULL
)	NULL
have	NULL
shown	NULL
that	NULL
sodium	NULL
salicylate	NULL
at	NULL
concentrations	NULL
as	NULL
high	NULL
as	NULL
20	NULL
mM	NULL
(	NULL
3.6	NULL
mg/ml	NULL
)	NULL
induces	NULL
HSF	NULL
binding	NULL
to	NULL
HSE	NULL
of	NULL
the	NULL
Hsp70	NULL
gene	NULL
,	NULL
even	NULL
though	NULL
it	NULL
was	NULL
unable	NULL
to	NULL
induce	NULL
Hsp70	NULL
transcription	NULL
in	NULL
HeLa	NULL
cells	NULL
We	NULL
found	NULL
HSF-1	NULL
binding	NULL
to	NULL
HSE	NULL
and	NULL
transcription	NULL
of	NULL
Hsp70	NULL
gene	NULL
only	NULL
at	NULL
aspirin	NULL
concentrations	NULL
of	NULL
40	NULL
mM	NULL
7.2	NULL
mg/	NULL
ml	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
Hsp60	NULL
is	NULL
induced	NULL
at	NULL
concentrations	NULL
of	NULL
aspirin	NULL
ranging	NULL
from	NULL
10	NULL
to	NULL
40	NULL
mM	NULL
.	NULL

Our	NULL
data	NULL
suggest	NULL
that	NULL
high	NULL
doses	NULL
of	NULL
aspirin	NULL
prevent	NULL
the	NULL
recruitment	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
even	NULL
of	NULL
known	NULL
specificity	NULL
)	NULL
into	NULL
sites	NULL
of	NULL
inflammation	NULL
via	NULL
suppression	NULL
of	NULL
adhesion	NULL
molecules	NULL
and	NULL
MCP-1	NULL
,	NULL
in	NULL
concert	NULL
with	NULL
the	NULL
finding	NULL
that	NULL
aspirin	NULL
inhibits	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

Neither	NULL
indomethacin	NULL
nor	NULL
CyA	NULL
showed	NULL
this	NULL
inhibitory	NULL
effect	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
C	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
aspirin	NULL
inhibited	NULL
the	NULL
proliferative	NULL
response	NULL
of	NULL
PBMC	NULL
to	NULL
influenza	NULL
virus	NULL
mix	NULL
in	NULL
vitro	NULL
,	NULL
a	NULL
suppression	NULL
that	NULL
was	NULL
effective	NULL
at	NULL
aspirin	NULL
concentrations	NULL
that	NULL
induced	NULL
Hsp60	NULL
expression	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
hypothesize	NULL
that	NULL
the	NULL
recruitment	NULL
of	NULL
anti-Hsp60-reactive	NULL
T	NULL
cells	NULL
into	NULL
arterial	NULL
intima	NULL
and	NULL
the	NULL
subsequent	NULL
initiation	NULL
of	NULL
a	NULL
reaction	NULL
against	NULL
Hsp60	NULL
could	NULL
be	NULL
prevented	NULL
by	NULL
aspirin	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
assume	NULL
that	NULL
the	NULL
induction	NULL
of	NULL
Hsp60	NULL
expression	NULL
by	NULL
aspirin	NULL
can	NULL
not	NULL
overcome	NULL
the	NULL
suppressive	NULL
effects	NULL
of	NULL
aspirin	NULL
on	NULL
adhesion	NULL
molecule	NULL
expression	NULL
.	NULL

We	NULL
have	NULL
also	NULL
demonstrated	NULL
that	NULL
addition	NULL
of	NULL
indomethacin	NULL
to	NULL
T	NULL
cell	NULL
cultures	NULL
failed	NULL
to	NULL
suppress	NULL
the	NULL
proliferative	NULL
response	NULL
to	NULL
influenza	NULL
antigen	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
1C	NULL
,	NULL
indomethacin	NULL
slightly	NULL
,	NULL
but	NULL
not	NULL
significantly	NULL
,	NULL
induced	NULL
T	NULL
cell	NULL
proliferation	NULL
,	NULL
and	NULL
also	NULL
reversed	NULL
immune	NULL
suppressive	NULL
phenomena	NULL
in	NULL
vivo	NULL
(	NULL
39	NULL
)	NULL
and	NULL
in	NULL
vitro	NULL
(	NULL
40,41	NULL
)	NULL
by	NULL
inhibiting	NULL
immune	NULL
cell	NULL
release	NULL
of	NULL
prostaglandin	NULL
,	NULL
which	NULL
inhibits	NULL
IL-2	NULL
production	NULL
and	NULL
hence	NULL
proliferation	NULL
of	NULL
responder	NULL
T	NULL
cells	NULL
(	NULL
41	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
indomethacin	NULL
did	NULL
not	NULL
inhibit	NULL
NF-KB	NULL
activity	NULL
and	NULL
adhesion	NULL
molecule	NULL
or	NULL
MCP-1	NULL
expression	NULL
in	NULL
EC	NULL
after	NULL
TNF-a	NULL
stimulation	NULL
,	NULL
and	NULL
induced	NULL
Hsp60	NULL
and	NULL
Hsp70	NULL
expression	NULL
only	NULL
at	NULL
high	NULL
doses	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
our	NULL
data	NULL
suggest	NULL
that	NULL
the	NULL
different	NULL
actions	NULL
of	NULL
immunosuppressive	NULL
agents	NULL
on	NULL
adhesion	NULL
molecule	NULL
,	NULL
MCP-1	NULL
,	NULL
and	NULL
Hsp60	NULL
expression	NULL
in	NULL
EC	NULL
could	NULL
overcome	NULL
the	NULL
suppression	NULL
of	NULL
the	NULL
cellular	NULL
immune	NULL
response	NULL
by	NULL
these	NULL
agents	NULL
,	NULL
and	NULL
may	NULL
explain	NULL
the	NULL
atherosclerosis-promoting	NULL
effect	NULL
of	NULL
CyA	NULL
and	NULL
the	NULL
protective	NULL
effect	NULL
of	NULL
aspirin	NULL
,	NULL
respectively	NULL
.	NULL

Further	NULL
investigations	NULL
on	NULL
immune	NULL
system	NULL
suppression	NULL
in	NULL
animal	NULL
models	NULL
of	NULL
atherosclerosis	NULL
will	NULL
elucidate	NULL
how	NULL
and	NULL
when	NULL
lymphocytes	NULL
influence	NULL
the	NULL
atherosclerotic	NULL
disease	NULL
pro-cess	NULL
.	NULL

Acknowledgements	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
the	NULL
Austrian	NULL
Research	NULL
Council	NULL
Project	NULL
12715	NULL
(	NULL
G.	NULL
W.	NULL
)	NULL
and	NULL
the	NULL
Sandoz	NULL
Foundation	NULL
for	NULL
Gerontological	NULL
Research	NULL
(	NULL
G.	NULL
W.	NULL
)	NULL
The	NULL
authors	NULL
thank	NULL
G.	NULL
Sturm	NULL
for	NULL
her	NULL
excellent	NULL
technical	NULL
assistance	NULL
and	NULL
T.	NULL
Ott	NULL
]	NULL
for	NULL
his	NULL
help	NULL
in	NULL
preparation	NULL
of	NULL
the	NULL
photographs	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Hansson	NULL
GK	NULL
,	NULL
Jonasson	NULL
L	NULL
,	NULL
Lojsthed	NULL
B	NULL
,	NULL
Stemme	NULL
S	NULL
,	NULL
Kocher	NULL
O0	NULL
,	NULL
and	NULL
Gabbiani	NULL
G.	NULL
(	NULL
1988	NULL
)	NULL
Localization	NULL
of	NULL
T	NULL
lymphocytes	NULL
and	NULL
macrophages	NULL
in	NULL
fibrous	NULL
and	NULL
complicated	NULL
human	NULL
atherosclerotic	NULL
plaques	NULL
.	NULL

Atherosclerosis	NULL
7A	NULL
:	NULL
135-141	NULL
.	NULL

2	NULL
.	NULL

Xu	NULL
Q	NULL
,	NULL
Oberhuber	NULL
G	NULL
,	NULL
Gruschwitz	NULL
M	NULL
,	NULL
and	NULL
Wick	NULL
G.	NULL
(	NULL
1990	NULL
)	NULL
Immunology	NULL
of	NULL
atherosclerosis	NULL
:	NULL
cellular	NULL
composition	NULL
and	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
II	NULL
antigen	NULL
expression	NULL
in	NULL
aortic	NULL
intima	NULL
,	NULL
fatty	NULL
streaks	NULL
,	NULL
and	NULL
atherosclerotic	NULL
plaques	NULL
in	NULL
young	NULL
and	NULL
aged	NULL
human	NULL
specimens	NULL
.	NULL

Clin	NULL
.	NULL

Immunol	NULL
.	NULL

Immu-nopathol	NULL
.	NULL

56	NULL
:	NULL
344-359	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

A.	NULL
Amberger	NULL
et	NULL
al	NULL
.	NULL

:	NULL
Effects	NULL
of	NULL
Anti-inflammatory	NULL
Agents	NULL
on	NULL
HUVECs	NULL
127	NULL
.	NULL

Hansson	NULL
GK	NULL
,	NULL
Holm	NULL
J	NULL
,	NULL
and	NULL
Jonasson	NULL
L.	NULL
(	NULL
1989	NULL
)	NULL
Detection	NULL
of	NULL
activated	NULL
T	NULL
lymphocytes	NULL
in	NULL
the	NULL
human	NULL
atherosclerotic	NULL
plaque	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Pathol	NULL
.	NULL

135	NULL
;	NULL
169-175.	NULL
.	NULL

Stemme	NULL
S	NULL
,	NULL
Holm	NULL
J	NULL
,	NULL
and	NULL
Hansson	NULL
GK	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
T	NULL
lymphocytes	NULL
in	NULL
human	NULL
atherosclerotic	NULL
plaques	NULL
are	NULL
memory	NULL
cells	NULL
expressing	NULL
CD45RO	NULL
and	NULL
the	NULL
integrin	NULL
VLA-1	NULL
.	NULL

Arterioscler	NULL
.	NULL

Thromb	NULL
.	NULL

12	NULL
;	NULL
206-211.	NULL
.	NULL

Xu	NULL
Q	NULL
,	NULL
Kleindienst	NULL
R	NULL
,	NULL
Waitz	NULL
W	NULL
,	NULL
Dietrich	NULL
H	NULL
,	NULL
Wick	NULL
G.	NULL
(	NULL
1993	NULL
)	NULL
Increased	NULL
expression	NULL
of	NULL
heat	NULL
shock	NULL
protein	NULL
65	NULL
coincides	NULL
with	NULL
a	NULL
population	NULL
of	NULL
infiltrating	NULL
T	NULL
lymphocytes	NULL
in	NULL
atherosclerotic	NULL
lesions	NULL
of	NULL
rabbits	NULL
specifically	NULL
responding	NULL
to	NULL
heat	NULL
shock	NULL
protein	NULL
65	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

91	NULL
;	NULL
2693-2702.	NULL
.	NULL

Zhou	NULL
X	NULL
,	NULL
Stemme	NULL
S	NULL
,	NULL
Hansson	NULL
GK	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Evidence	NULL
for	NULL
a	NULL
local	NULL
immune	NULL
response	NULL
in	NULL
atherosclerosis	NULL
:	NULL
CD4+	NULL
T-cells	NULL
infiltrate	NULL
lesions	NULL
of	NULL
APO	NULL
E-deficient	NULL
mice	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Pathol	NULL
.	NULL

149	NULL
;	NULL
359-366.	NULL
.	NULL

Wick	NULL
G	NULL
,	NULL
Kleindienst	NULL
R	NULL
,	NULL
Dietrich	NULL
H	NULL
,	NULL
Xu	NULL
Q	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Is	NULL
atherosclerosis	NULL
an	NULL
autoimmune	NULL
disease	NULL
?	NULL

Trends	NULL
Food	NULL
Sci	NULL
.	NULL

Technol	NULL
.	NULL

3	NULL
:	NULL
114-119.	NULL
.	NULL

Wick	NULL
G	NULL
,	NULL
Schett	NULL
G	NULL
,	NULL
Amberger	NULL
A	NULL
,	NULL
Kleindienst	NULL
R	NULL
,	NULL
Xu	NULL
Q	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Is	NULL
atherosclerosis	NULL
an	NULL
immunologically	NULL
mediated	NULL
disease	NULL
?	NULL

Immunol	NULL
.	NULL

Today	NULL
16	NULL
:	NULL
27-33.	NULL
.	NULL

Xu	NULL
Q	NULL
,	NULL
Dietrich	NULL
H	NULL
,	NULL
Steiner	NULL
HJ	NULL
,	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Induc-	NULL
tion	NULL
of	NULL
arteriosclerosis	NULL
in	NULL
normocholesterolemic	NULL
rabbits	NULL
by	NULL
immunization	NULL
with	NULL
heat	NULL
shock	NULL
protein	NULL
65	NULL
.	NULL

Arterioscler	NULL
.	NULL

Thromb	NULL
.	NULL

121	NULL
789-799	NULL
.	NULL

Xu	NULL
Q	NULL
,	NULL
Willeit	NULL
J	NULL
,	NULL
Marosi	NULL
M	NULL
,	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Association	NULL
of	NULL
serum	NULL
antibodies	NULL
to	NULL
heat	NULL
shock	NULL
protein	NULL
65	NULL
with	NULL
carotid	NULL
atherosclerosis	NULL
.	NULL

Lancet	NULL
341	NULL
:	NULL
255-259	NULL
.	NULL

Ellis	NULL
RJ	NULL
,	NULL
van	NULL
der	NULL
Vies	NULL
SM	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Molecular	NULL
chap-erones	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

60	NULL
:	NULL
321-347	NULL
.	NULL

Lamb	NULL
JR	NULL
,	NULL
Bal	NULL
V	NULL
,	NULL
Mendez-Samperio	NULL
P	NULL
,	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Stress	NULL
proteins	NULL
may	NULL
provide	NULL
a	NULL
link	NULL
between	NULL
the	NULL
immune	NULL
response	NULL
to	NULL
infection	NULL
and	NULL
autoimmunity	NULL
.	NULL

Int	NULL
.	NULL

Immunol	NULL
.	NULL

1	NULL
:	NULL
2-6	NULL
.	NULL

Welch	NULL
WJ	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Mammalian	NULL
stress	NULL
response	NULL
:	NULL
cell	NULL
physiology	NULL
,	NULL
structure/function	NULL
of	NULL
stress	NULL
proteins	NULL
and	NULL
implications	NULL
for	NULL
medicine	NULL
and	NULL
disease	NULL
.	NULL

Physiol	NULL
.	NULL

Rev	NULL
.	NULL

72	NULL
;	NULL
1063-1081	NULL
.	NULL

Ross	NULL
R.	NULL
(	NULL
1993	NULL
)	NULL
The	NULL
pathogenesis	NULL
of	NULL
atherosclerosis	NULL
:	NULL
a	NULL
perspective	NULL
for	NULL
the	NULL
1990	NULL
.	NULL

Nature	NULL
362	NULL
:	NULL
801-809	NULL
.	NULL

Springer	NULL
TA	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Traffic	NULL
signals	NULL
for	NULL
lymphocyte	NULL
recirculation	NULL
and	NULL
leukocyte	NULL
emigration	NULL
:	NULL
the	NULL
mul-tistep	NULL
paradigm	NULL
.	NULL

Cell	NULL
76	NULL
:	NULL
301-314	NULL
.	NULL

Van	NULL
der	NULL
Wal	NULL
AC	NULL
,	NULL
Das	NULL
PK	NULL
,	NULL
Tigges	NULL
AJ	NULL
,	NULL
Becker	NULL
AE	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Adhesion	NULL
molecules	NULL
on	NULL
the	NULL
endothelium	NULL
and	NULL
mononuclear	NULL
cells	NULL
in	NULL
human	NULL
atherosclerotic	NULL
lesions	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Pathol	NULL
.	NULL

141	NULL
;	NULL
1427-1433	NULL
.	NULL

Printseva	NULL
OY	NULL
,	NULL
Peclo	NULL
MM	NULL
,	NULL
Gown	NULL
AM	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Various	NULL
cell	NULL
types	NULL
in	NULL
human	NULL
atherosclerotic	NULL
lesions	NULL
express	NULL
ICAM-1	NULL
.	NULL

Further	NULL
immunocytochemical	NULL
and	NULL
immunochemical	NULL
studies	NULL
employing	NULL
mono-clonal	NULL
antibody	NULL
10F3	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Pathol	NULL
.	NULL

140	NULL
;	NULL
889-896	NULL
.	NULL

Li	NULL
H	NULL
,	NULL
Cybulsky	NULL
MI	NULL
,	NULL
Gimbrone	NULL
MA	NULL
Jr	NULL
,	NULL
Libby	NULL
P.	NULL
(	NULL
1993	NULL
)	NULL
Inducible	NULL
expression	NULL
of	NULL
vascular	NULL
cell	NULL
adhesion	NULL
molecule-1	NULL
by	NULL
vascular	NULL
smooth	NULL
muscle	NULL
cells	NULL
19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32.	NULL
in	NULL
vitro	NULL
and	NULL
within	NULL
rabbit	NULL
atheroma	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Pathol	NULL
.	NULL

143	NULL
:	NULL
1551-1559	NULL
.	NULL

Seitz	NULL
SC	NULL
,	NULL
Kleindienst	NULL
R	NULL
,	NULL
Xu	NULL
Q	NULL
,	NULL
Wick	NULL
G.	NULL
(	NULL
1996	NULL
)	NULL
Co-expression	NULL
of	NULL
heat	NULL
shock	NULL
protein	NULL
60	NULL
and	NULL
intercellular	NULL
adhesion	NULL
molecule-1	NULL
is	NULL
related	NULL
to	NULL
increased	NULL
adhesion	NULL
of	NULL
monocytes	NULL
and	NULL
T-cells	NULL
to	NULL
aortic	NULL
endothelium	NULL
of	NULL
rats	NULL
in	NULL
response	NULL
to	NULL
endotoxin	NULL
.	NULL

Lab	NULL
.	NULL

Invest	NULL
.	NULL

74	NULL
;	NULL
241-252	NULL
.	NULL

Amberger	NULL
A	NULL
,	NULL
Maczeck	NULL
C	NULL
,	NULL
Jiirgens	NULL
G	NULL
,	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Co-expression	NULL
of	NULL
ICAM-1	NULL
,	NULL
VCAM-1	NULL
,	NULL
ELAM-1	NULL
and	NULL
Hsp60	NULL
in	NULL
human	NULL
arterial	NULL
and	NULL
venous	NULL
endothelial	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
cytokines	NULL
and	NULL
oxidized	NULL
low	NULL
density	NULL
lipoproteins	NULL
.	NULL

Cell	NULL
Stress	NULL
Chaperones	NULL
2	NULL
:	NULL
94-103	NULL
.	NULL

Roselaar	NULL
SE	NULL
,	NULL
Schonfeld	NULL
G	NULL
,	NULL
Daugherty	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Enhanced	NULL
development	NULL
of	NULL
atherosclerosis	NULL
in	NULL
cholesterol-fed	NULL
rabbits	NULL
by	NULL
suppression	NULL
of	NULL
cell-mediated	NULL
immunity	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

96	NULL
:	NULL
1389-1394	NULL
.	NULL

Emeson	NULL
EE	NULL
,	NULL
Shen	NULL
M-L.	NULL
(	NULL
1993	NULL
)	NULL
Accelerated	NULL
atherosclerosis	NULL
in	NULL
hyperlipidemic	NULL
C57BL/6	NULL
mice	NULL
treated	NULL
with	NULL
cyclosporin	NULL
A	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Pathol	NULL
.	NULL

142	NULL
;	NULL
1906-1915	NULL
.	NULL

Ridker	NULL
PM	NULL
,	NULL
Cushman	NULL
M	NULL
,	NULL
Stampfer	NULL
MJ	NULL
,	NULL
Tracy	NULL
RP	NULL
,	NULL
Hennekens	NULL
CH	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Inflammation	NULL
,	NULL
aspirin	NULL
and	NULL
the	NULL
risk	NULL
of	NULL
cardiovascular	NULL
disease	NULL
in	NULL
apparently	NULL
healthy	NULL
men	NULL
.	NULL

N.	NULL
Engl	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

336	NULL
:	NULL
973-979	NULL
.	NULL

Collins	NULL
T	NULL
,	NULL
Read	NULL
MA	NULL
,	NULL
Neish	NULL
AS	NULL
,	NULL
Whitley	NULL
MZ	NULL
,	NULL
Tha-nos	NULL
D	NULL
,	NULL
Maniatis	NULL
T.	NULL
(	NULL
1995	NULL
)	NULL
Trancriptional	NULL
regulation	NULL
of	NULL
endothelial	NULL
cell	NULL
adhesion	NULL
molecules	NULL
:	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
cytokine-inducible	NULL
enhancers	NULL
.	NULL

FASEB	NULL
J	NULL
.	NULL

9	NULL
:	NULL
899-909	NULL
.	NULL

Kopp	NULL
E	NULL
,	NULL
Ghosh	NULL
S.	NULL
(	NULL
1994	NULL
)	NULL
Inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
sodium	NULL
salicylate	NULL
and	NULL
aspirin	NULL
.	NULL

Science	NULL
265	NULL
:	NULL
956-959	NULL
.	NULL

Weber	NULL
C	NULL
,	NULL
Erl	NULL
W	NULL
,	NULL
Pietsch	NULL
A	NULL
,	NULL
Weber	NULL
P.	NULL
(	NULL
1995	NULL
)	NULL
Aspirin	NULL
inhibits	NULL
nuclear	NULL
factor-	NULL
«	NULL
B	NULL
mobilization	NULL
and	NULL
monocyte	NULL
adhesion	NULL
in	NULL
stimulated	NULL
human	NULL
endothelial	NULL
cells	NULL
.	NULL

Circulation	NULL
.	NULL

91	NULL
:	NULL
1914-1917	NULL
.	NULL

Grubeck-Loebenstein	NULL
B	NULL
,	NULL
Londei	NULL
M	NULL
,	NULL
Greenal	NULL
C	NULL
,	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Pathogenic	NULL
relevance	NULL
of	NULL
HLA	NULL
class	NULL
II	NULL
expressing	NULL
thyroid	NULL
follicular	NULL
cells	NULL
in	NULL
nontoxic	NULL
goiter	NULL
and	NULL
Graves	NULL
disease	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

81	NULL
:	NULL
1608-1614	NULL
.	NULL

Chomczynski	NULL
P	NULL
,	NULL
Sacchi	NULL
N.	NULL
(	NULL
1987	NULL
)	NULL
.	NULL

Single-step	NULL
method	NULL
of	NULL
RNA	NULL
isolation	NULL
by	NULL
acid	NULL
guanidinium	NULL
thiocyanate-phenol-chloroform	NULL
extraction	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

162	NULL
:	NULL
156-159	NULL
.	NULL

Church	NULL
GM	NULL
,	NULL
Gilbert	NULL
W.	NULL
(	NULL
1984	NULL
)	NULL
Genomic	NULL
sequenc-ing	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.S.A.	NULL
81	NULL
:	NULL
1991-1995	NULL
.	NULL

Nicoletti	NULL
I	NULL
,	NULL
Migliorati	NULL
G	NULL
,	NULL
Pagliacci	NULL
MC	NULL
,	NULL
Grignani	NULL
F	NULL
,	NULL
Riccardi	NULL
C.	NULL
(	NULL
1991	NULL
)	NULL
A	NULL
rapid	NULL
and	NULL
simple	NULL
method	NULL
for	NULL
measuring	NULL
thymocyte	NULL
apoptosis	NULL
by	NULL
propidium	NULL
iodide	NULL
staining	NULL
and	NULL
flow	NULL
cytometry	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

Methods	NULL
13	NULL
:	NULL
271-279	NULL
.	NULL

Schreiber	NULL
SL	NULL
,	NULL
Crabtree	NULL
GR	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
The	NULL
mechanism	NULL
of	NULL
action	NULL
of	NULL
cyclosporin	NULL
A	NULL
and	NULL
FK506	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
.	NULL

13	NULL
:	NULL
136-142	NULL
.	NULL

Cockerill	NULL
GW	NULL
,	NULL
Bert	NULL
AG	NULL
,	NULL
Ryan	NULL
GR	NULL
,	NULL
Gamble	NULL
JR	NULL
,	NULL
Vadas	NULL
MA	NULL
,	NULL
Cockerill	NULL
PN	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Regulation	NULL
of	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
fac-	NULL
128	NULL
33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

Molecular	NULL
Medicine	NULL
,	NULL
Volume	NULL
5	NULL
,	NULL
Number	NULL
2	NULL
,	NULL
February	NULL
1999	NULL
tor	NULL
and	NULL
E-selectin	NULL
expression	NULL
in	NULL
endothelial	NULL
cells	NULL
by	NULL
cyclosporin	NULL
A	NULL
and	NULL
the	NULL
T-cell	NULL
transcription	NULL
factor	NULL
NFAT	NULL
.	NULL

Blood	NULL
86	NULL
:	NULL
2689-2698	NULL
.	NULL

Zimarino	NULL
V	NULL
,	NULL
Tsai	NULL
C	NULL
,	NULL
Wu	NULL
C.	NULL
(	NULL
1989	NULL
)	NULL
Complex	NULL
modes	NULL
of	NULL
heat	NULL
shock	NULL
factor	NULL
activation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
:	NULL
752-759	NULL
.	NULL

Drew	NULL
AF	NULL
,	NULL
and	NULL
Tipping	NULL
PG	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Cyclosporine	NULL
treatment	NULL
reduces	NULL
early	NULL
atherosclerosis	NULL
in	NULL
the	NULL
cholesterol-fed	NULL
rabbit	NULL
.	NULL

Atherosclerosis	NULL
116	NULL
:	NULL
181-189	NULL
.	NULL

Weismann	NULL
G.	NULL
(	NULL
1991	NULL
)	NULL
.	NULL

Aspirin	NULL
.	NULL

Sci	NULL
.	NULL

Am	NULL
.	NULL

264	NULL
:	NULL
84-92	NULL
.	NULL

Pierce	NULL
JW	NULL
,	NULL
Read	NULL
MA	NULL
,	NULL
Ding	NULL
H	NULL
,	NULL
Luscinskas	NULL
FW	NULL
,	NULL
Collins	NULL
,	NULL
T.	NULL
(	NULL
1996	NULL
)	NULL
Salicylate	NULL
inhibit	NULL
IkB-a	NULL
phos-phorylation	NULL
,	NULL
endothelial-leukocyte	NULL
adhesion	NULL
molecule	NULL
expression	NULL
,	NULL
and	NULL
neutrophil	NULL
transmigration	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

156	NULL
;	NULL
3961-3969	NULL
.	NULL

Palmoski	NULL
MJ	NULL
,	NULL
Brandt	NULL
KD	NULL
.	NULL

(	NULL
1984	NULL
)	NULL
Effects	NULL
of	NULL
salicylate	NULL
and	NULL
indomethacin	NULL
on	NULL
glycosaminoglycan	NULL
and	NULL
38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41.	NULL
prostaglandin	NULL
E2	NULL
synthesis	NULL
in	NULL
intact	NULL
canine	NULL
knee	NULL
cartilage	NULL
ex	NULL
vivo	NULL
.	NULL

Arthritis	NULL
Rheum	NULL
.	NULL

27	NULL
;	NULL
398-404	NULL
.	NULL

Jurivich	NULL
DA	NULL
,	NULL
Sistonen	NULL
L	NULL
,	NULL
Kroes	NULL
RA	NULL
,	NULL
Morimoto	NULL
RL	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Effect	NULL
of	NULL
sodium	NULL
salicylate	NULL
on	NULL
the	NULL
human	NULL
heat	NULL
shock	NULL
response	NULL
.	NULL

Science	NULL
25	NULL
:	NULL
1243-1245	NULL
.	NULL

Hernandez-Pando	NULL
R	NULL
,	NULL
Orozco	NULL
H	NULL
,	NULL
Mancilla	NULL
R.	NULL
(	NULL
1995	NULL
)	NULL
T-cell	NULL
lung	NULL
granulomas	NULL
induced	NULL
by	NULL
sepha-rose-coupled	NULL
mycobacterium	NULL
tuberculosis	NULL
protien	NULL
antigens	NULL
:	NULL
immunosuppressive	NULL
phenomena	NULL
reversed	NULL
with	NULL
cyclophosphamide	NULL
and	NULL
indometha-cin	NULL
.	NULL

Immunology	NULL
8	NULL
:	NULL
506-511	NULL
.	NULL

Stefanovic	NULL
H	NULL
,	NULL
Filion	NULL
LG	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Effect	NULL
of	NULL
IL-2	NULL
and	NULL
indomethacin	NULL
on	NULL
the	NULL
activation	NULL
of	NULL
suppressor	NULL
cells	NULL
induced	NULL
by	NULL
tetanus	NULL
toxoid	NULL
.	NULL

Immunobiology	NULL
18	NULL
:	NULL
345-356	NULL
.	NULL

Marcinkiewicz	NULL
J	NULL
,	NULL
Grabowska	NULL
A	NULL
,	NULL
Chain	NULL
BM	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

Is	NULL
there	NULL
a	NULL
role	NULL
for	NULL
nitric	NULL
oxide	NULL
in	NULL
regulation	NULL
of	NULL
T	NULL
cell	NULL
secretion	NULL
of	NULL
I1-2	NULL
?	NULL

J.	NULL
Immunol	NULL
.	NULL

15	NULL
:	NULL
4617-4621	NULL
.	NULL

